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 Intrinsically disordered proteins (IDPs) have regions that are highly flexible and lack 
stable secondary or tertiary structure. Recently, there has been a growing interest in IDPs due to 
their important roles in many biological processes and functions. Although many studies have 
shown that IDPs participate in functional interactions, less is known about the structural details 
of the interactions. Over the past two decades, mass spectrometry (MS) has become a powerful 
technique for biophysical characterization of proteins due to its high sensitivity and variety of 
choices for sample preparation and instrumentation. Here I present the application of two 
important mass spectrometry-based approaches: hydrogen exchange (HX) and fast 
photochemical oxidation of proteins (FPOP) to study disordered proteins.  
HX-MS was applied to better understand the mechanism of calcineurin activation. 
Calcineurin is a heterodimeric phosphatase that plays essential roles in cellular processes. 
Previous work has established that at high calcium concentration, calmodulin binds calcium ions, 
resulting in calmodulin binding to the intrinsically disordered regulatory domain of calcineurin. 
Calmodulin binding causes release of the autoinhibitory domain from the active site, activating 
calcineurin. My results with full-length calcineurin demonstrate that the regulatory domain is 
unstructured in the absence of calmodulin, while it folds upon binding to calmodulin. This result 
confirms previous work on the isolated regulatory-autoinhibitory domain construct. Additionally, 
I have observed calmodulin-induced changes in peptides located in other domains of calcineurin. 
Finally, and surprisingly, I found no changes in the structuring of the calcineurin autoinhibitory 
domain upon calmodulin binding. I present results from all regions of the calcineurin to describe 
the mechanism of calcineurin activation. I also propose a new model of calcineurin activation 
upon calmodulin binding. 
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The degree of structure measurement in IDPs can provide important information about 
the mechanisms by which IDPs undergo coupled folding and binding. Different approaches to 
quantify the degree of structure in IDPs using millisecond HX were explored. A quench-flow 
device, built in-house, for HX labeling on the millisecond timescale was employed. It is 
essentially impossible to determine the degree of structure without having an accurate 
unprotected reference state. The interaction domains of the activator for thyroid and retinoid 
receptors (ACTR) and the CREB binding protein (CBP) were used as model IDPs to explore the 
best approach to produce an unprotected reference state for millisecond HX. ACTR is a near-
random coil IDP that has some residual helicity while CBP is a molten globular IDP that 
transiently becomes unstructured as revealed by NMR and HX-MS. The approaches explored to 
obtain an unprotected reference state in HX experiments were chemical exchange calculations, 
addition of denaturing agents, and millisecond HX labeling of peptic peptides obtained from the 
IDP. It was found that peptic reference peptides can be used as an accurate unprotected reference 
state for determining the degree of the structure. 
Due to its fast labeling timeframe, FPOP might reveal states of IDPs that are undetectable 
by HX. The application of the FPOP technique for characterizing IDPs was also evaluated. To 
explore the applicability of this technique for studying IDPs, ACTR and CBP as model systems 
that co-fold upon binding were used. The FPOP technique was utilized to study ACTR and CBP 
in their free and bound forms. The data show that FPOP provided useful information to compare 
two states of IDPs. The usefulness and limitations of FPOP analysis to characterize and localize 
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1.1 Intrinsically disordered proteins 
1.1.1 Classification of disorder and the protein quartet 
Proteins are a class of biological molecules that are involved in nearly all cell processes. 
Although some degree of flexibility was allowed in a protein molecule, it has been pointed out 
that protein function is directly related to protein’s three dimensional structure.
(1)
 In 1894, Emil 
Fischer proposed the lock-and-key model to describe the molecular mechanism of enzymatic 
activity.
(2)
 This model has been more supported after successful resolution of many protein 
structures by X-ray crystallography, which results in reinforcing a static view of functional 
proteins. The structure-function paradigm became the center of many major directions of protein 
science like enzymatic catalysis, proteomics, protein misfolding, allosteric interactions, protein 
self-organization, bio-medicine, and protein engineering.
(3)
 In fact, even the most well-defined 
proteins are considered dynamic systems having different degrees of conformational flexibility. 
These well-defined proteins undergo structural rearrangements of relatively small scale and 
relatively quickly.
(4, 5)
 However, there is a different class of proteins that exhibit a high degree of 
conformational flexibility and lack a structured conformation under physiological conditions, but 
are still functional.
(6-10)
 In the literature, several terms have been used to describe this class of 









 and intrinsically disordered.
(15)
 In this dissertation, these proteins will be referred to 
as intrinsically disordered proteins (IDPs). Generally, IDPs lack bulky hydrophobic amino acids 
that make up the hydrophobic core in forming a well-defined structure.
(16, 17)
 Hence, the IDPs 
functionality arises in a different manner as compared to the classical structure-function model of 
ordered proteins.
(3)
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In general, based on the degree of disorder, proteins can be categorized into a quartet of 
states.
(18)
 These states are ordered, pre-molten globule, molten globule, and random coil. It has 
been proposed that protein function can arise from any of these four states and from transitions 
between them.
(18)
 Figure 1.1 shows a schematic representation of the continuum model of protein 
structure. Folded proteins tend to have well-defined secondary and tertiary structural elements 
that have formed from the folding of the protein.
(19)
 The stable folded state of a protein limits the 
number and variability of different conformers of folded proteins.
(18, 19)
 The structure-disorder 
space of a protein is considered as a continuum, and there is no distinct boundary among 
disordered proteins on the continuum. The molten globule is a state that is located in the middle 
of the continuum. Molten globular proteins are loosely defined proteins that retain secondary 
structural elements but lack a stable tertiary fold.
(20-22)
 The pre-molten globule is a state that has 
high conformational flexibility which makes the secondary structure of the protein undergo 
transient disruptions.
(23, 24)
 The transient disruption of the secondary structures causes the protein 
hydrodynamic radius to become even larger, which in turn allows IDPs to bind to targets from a 
larger distance.
(23)
 Although proteins can be theoretically categorized into random coils that have 







Figure 1.1. Schematic representation of the continuum model of protein structure. The 
continuum of conformational states ranging from highly dynamic and expanded conformational 
ensemble (left) to compact and fully folded globular states (right). Dynamically disordered states 
are represented by lines and folded structures are represented by cartoons. Redrawn from Ref. 
(18).     
 
1.1.2 Abundance of IDPs in various proteomes 
 Several prediction algorithms have been applied to proteome databases to identify the 
prevalence of disordered proteins.
(16, 26-29)
 These predictions revealed that IDPs and intrinsically 
disordered regions are prevalent in eukaryotic genomes.
(26, 30-32)
 For example, a study revealed 
that a 44% of human protein-coding genes contain regions of predicted extended disorder of >30 
amino acids in length.
(33)
 The study also showed that 6% of all protein-coding genes of the 
human genome do not have any function annotation in their description, and these genes contain 
more predicted IDPs. Other studies showed that eukaryotic proteomes exhibit more disorder than 
prokaryotic or archaea proteomes with C. elegans, A. thaliana, S. cerevisiae, and D. 
melanogaster predicted to have 52-67% of proteins with intrinsically disordered regions, while 
bacteria and archaea were predicted to have 16-45 and 26-51% of proteins with disordered 
regions, respectively.
(26, 30)
 These predictions of high frequency of IDPs in eukaryotic proteomes 
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may indicate the IDPs importance to perform necessary functions in multicellular eukaryotic 
organisms.
(34)
   
1.1.3 IDPs and human diseases 
 IDPs have an important role in many biological processes and functions. The biological 
functions include transcriptional regulation, cellular signaling, post-translational modification, 
and cellular recognition.
(10, 35, 36)
 Dysregulation of IDPs in many biological processes has been 
linked to a number of human diseases.
(37-40)
 One of the disease states is cancer.
(15)
 There is a 
strong association between IDPs and cancer-associated proteins, and examples of the IDPs 
associated with the cancer disease are p53,
(41)




 and a thyroid 
cancer associated protein, TC-1.
(44)
 Furthermore, there are several IDPs involved in 







 and prion diseases.
(47)
 The IDPs involved in these disease states are tau-protein, α-
synuclein, amyloid-β, and PeP
SC
. The neurogenerative diseases are also called conformational 
diseases because the disease occurs due to conformational changes, misfolding, and aggregation 
of the proteins linked to the disease states.
(3)
 In addition, there are IDPs, α-synuclein, for 
example, associated with neurodegenerative diseases because of dysregulation in protein 
functionality rather than only conformational disorders.
(3)
 The funtions attributed to α-synuclein 




1.1.4 Coupled folding and binding mechanism 
One of the properties of IDPs is their highly dynamic conformations that mediate protein-
protein interaction through the phenomenon of coupled folding and binding.
(21, 48, 49)
 In this type 
of interaction, folding of a disordered protein occurs upon engagement with its binding partner. 
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Therefore, there are two necessary events in coupled folding and binding mechanism: a 
conformational change and a binding step.
(50)
 There has been considerable debate about the order 
of these events.
(50)
 Two extreme mechanisms have been proposed. Conformational selection is 
one of the mechanisms of binding proposed in IDP interactions.
(51, 52)
 According to this mode of 
binding, transiently folded states, which can exist within conformational ensembles of disordered 
proteins, can be selected by the binding partner to allow binding. The other mode of binding is 
the induced folding mode.
(51, 52)
 In this case, the conformation flexibility of a disordered protein 
can ease the binding with its binding partner. This binding leads to folding the disordered 
protein. Although differentiation of these two mechanisms is an ongoing challenge, it is possible 
that processes might have elements of both mechanisms depending upon experimental conditions 
including protein concentration.
(50)
 One example of processes having elements of both 
mechanisms is c-Myb and CBP. A recent paper showed that a disordered protein, c-Myb, binds 
to the binding site on the KIX domain of CBP by a mechanism that combines elements of both 
conformational selection and induced folding.
(53)
 Away from which mechanism is taking place, 
another property of IDPs is their ability to return to the highly flexibile conformations after the 
completion of a specific function and their tendency to obtain different conformations depending 
on the environmental particularities.
(3)
  
1.1.5 Model IDPs: ACTR and CBP 
In this dissertation, two model IDPs are studied extensively in chapters 2, 3, and 4. These 
proteins are a binding domain of human p160 coactivator, activator for thyroid and retinoid 
receptors (residues 1023-1093, hereafter referred to as ACTR) and the nuclear coactivator 
binding domain (NCBD) of mouse cAMP-responsive element (CRE)-binding (CREB) binding 
protein (residues 2059-2117, hereafter referred to as CBP). There are extensive data 
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characterizing ACTR and CBP proteins in both isolated and complex forms.
(21, 54-56)
 ACTR is a 
near-random coil IDP that transiently become structured (so-called residual structure),
(54-56)
 while 
CBP is a molten globular IDP that transiently becomes unstructured
(55-57)
 (see Figures 1.2a and 
b). As reported in the case of the interaction between some IDPs, the interaction between ACTR 
and CBP occurs through a process of mutual induced folding.
(21)
 The isolated forms of ACTR 
and CBP are disordered, while they form a tight and structured complex when bound to each 




 In chapter 3, isolated forms of ACTR 
and CBP have been used as model systems to identify the best approach to measure residual 
structure of IDPs. In chapter 4, both isolated and complex forms of ACTR and CBP have been 
used to evaluate the application of fast photochemical oxidation of protein mass spectrometry to 




Figure 1.2. Cartoon representation of isolated (a) ACTR and (b) CBP and (c) their complex 
form. ACTR is a near-random coil IDP that transiently becomes structured. CBP is a molten 
globular IDP that transiently becomes unstructured. ACTR and CBP form a structured complex 






In chapter 2 of this dissertation, I studied human calcineurin (CaN), an IDP that has two 
unstructured regulatory regions. CaN is a heterodimeric serine/threonine phosphatase activated 
by calcium and calmodulin (CaM) binding.
(58-61)
 CaN plays important roles in various cellular 
and biological processes such as T-cell activation, muscle contraction, neuronal signaling, and 
cardiac growth.
(60)
 CaN has two subunits (A and B chains). There are four distinct functional 
domains in CaN A: a catalytic domain, a CaN B-binding domain, a calmodulin-binding domain, 
and an auto-inhibitory domain
(62)
 . In its free form, CaN has two unstructured regulatory regions, 
the C-terminal domain and the regulatory domain (except for a short, structured autoinhibitory 
region, see section 2.1 for more details).  Depending on the calcium concentrations in the cell, 
CaN undergoes sequential conformational changes to become fully activated.
(63)
 Chapter 2 of 
this dissertation begins with a review of CaN activation models. Next, hydrogen exchange mass 
spectrometry has been used to understand the mechanism of CaN activation in solution after 
calmodulin binding.  
1.2 Detecting and characterizing IDPs 
 Many techniques have been used to identify and characterize IDPs. Some of the 
techniques are considered indirect because they do not directly provide structural information 
and only provide global properties of a particular protein under study. These techniques include 
resistance to heat and chemical denaturation, limited proteolysis, and differential scanning 
calorimetry. Others techniques provide information on the size or hydrodynamic property of 
IDPs, such as gel filtration chromatography, dynamic light scattering, small-angle X-ray 
scattering, and analytical ultracentrifugation. Since the conformational behavior of IDPs is 
different from that of ordered proteins, many spectroscopic techniques have been used to provide 
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both steady-state and dynamic structural information on IDPs at low and high resolution. Some 
of the computational and experimental techniques will be discussed.      
1.2.1 Computational prediction of IDPs 
It has been reported that the amino acid sequences of IDPs are different from the 
sequences of ordered proteins.
(15, 16, 64)
 IDPs tend to have both low content of hydrophobic and 
high content of similarly charged residues. In a more detailed comparison of amino acid 
sequences, it has been found that IDPs are depleted in order-promoting amino acids with 
aromatic or bulky aliphatic side-chains (Trp, Tye, Phe, Ile, Leu, and Val), and IDPs also have 
low content of Cys and Asn residues. On the other hand, IDPs tend to be enriched in disorder-
promoting residues like Ala, Arg, Gly, Gln, Ser, Glu, and Lys, and also possess high content of 
the structure-breaking residue, Pro.
(15, 35, 65)
 The differences between disordered and ordered 
proteins were not only limited to their amino acid composition, but can also be discriminated 
using some other physico-chemical properties, such as flexibility, hydropathy, β-sheet 
propensity, bulkiness, content of order and disorder-promoting residues, and net charge.
(15)
 These 
properties became great resources to develop various computational tools to predict IDPs. There 
are about 70 predictors that are based on different principles and different computational 
approaches.
(66)
 Among these predictors, the Predictor Of Natural Disordered Regions (PONDR) 
was one of the first developed predictors.
(67, 68)
 PONDR is based on a sophisticated approach that 
uses algorithms trained to distinguish sequences that encode for disorder from those that encode 
for order. PONDR scores provide the propensity for amino acids to be disordered on a residue by 
residue basis. Residues with PONDR scores greater than 0.5 are predicted to be disordered, 
while scores below 0.5 are predicted to be ordered. Several versions of PONDR have been 
developed and one of its versions is specific for predicting short recognition elements is (VL-
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XT). The PONDR-VL_XT algorithm 
(67, 69, 70)
predictions for ACTR, CBP, and CaN are shown in 
Figure 1.3. The disorder prediction for ACTR indicates that all regions of ACTR are predicted to 
be disordered except for the middle region (residue 32-44) which is predicted to be slightly 
ordered. For CBP, the N-terminal region is predicted to be disordered, but the C-terminal region 
is predicted to be ordered. The prediction for CaN indicates that the regulatory domain is 
disordered except for a short region which is predicted to be ordered. The prediction for CaN 
correlates well with the structure of calcineurin determined by X-ray crystallography (see section 
2.1 for the calcineurin domain structure).
(62)
 Although disorder predictors can provide predictions 
based on amino acid sequences, these predictors cannot predict folding or unfolding that results 
from binding or solvent conditions. These weaknesses necessitate relying on experimental 




Figure 1.3. The PONDR-VL-XT disorder prediction for (a) ACTR, (b) CBP, and (c) calcineurin 
A chain. Residues with PONDR scores greater than 0.5 are predicted to be disordered and scores 
less than 0.5 are predicted to be ordered. The regulatory domain of calcineurin A chain is 
predicted to be disordered, which includes the calmodulin binding domain (CaMBD), blue 
shading and the autoinhibitory domain (AID), red shading. 
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1.2.2 Circular dichroism spectroscopy    
One of the spectroscopic methods to identify IDPs is circular dichroism (CD). This 
method is based on measuring the difference of absorption of left-handed and right-handed 
circularly polarized light, which results from the chiral molecules.
(52, 71, 72)
 Far-UV CD in the 
190-230 nm region originates from optically active amide peptide bonds.
(72, 73)
 It can be used to 
determine the relative amount of secondary structure content and also to distinguish α-helix, β-
sheet, and random coil conformations. Near-UV CD in the range 250-350 nm region can also be 
a useful region to provide information on the tertiary structure because aromatic residues tend to 
have distinct wavelength profiles.
(73, 74)
 CD has been a main technique for identification of IDPs 
and also for characterization of IDP structural changes induced by pH change, chemical 
denaturants, or temperature. Some examples of IDPs that were first classified as disordered 






 One of 
the limitations of CD is that it cannot provide local structural information. 
1.2.3 X-ray crystallography 
The use of X-ray crystallography is not effective for analyzing fully disordered proteins 
due to these proteins’ high conformational flexibility in their native states. The highly flexible 
nature makes these proteins unlikely to crystalize and even if they crystallize, the crystal state 
may not represent the native conformation.
(76)
 However, the use of X-ray crystallography can be 
beneficial to analyze flexibility of regions within an ordered protein.
(15)
 In fact, the 
crystallography method can be used as a reliable source of information on protein dynamics by 
analyzing the temperature-factor of atoms, also termed the B-factor, which can be taken as 
indicating the relative motion of different parts of the protein structure.
(77)
 Atoms with high B-
factors indicate that these atoms belong to part of the structure that is very flexible, and vice 
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versa. In addition, absence of electron density in protein structures very likely corresponds to 
disordered regions because increased mobility of atoms in these regions makes these atoms 
invisible by X-ray crystallography. There are a significant number of proteins in the DisProt 
database, a database for disordered proteins, having X-ray crystallography listed as their method 
of detection.
(62, 78)
 One of the examples of an IDP that has a disordered region in its structure is 
calcineurin.
(62)
 Calcineurin has a 95 residue region connecting two domains. Chapter 2 of this 
dissertation includes the structural study of this IDP in its free and complex forms.  
1.2.4 Nuclear magnetic resonance spectroscopy 
 Nuclear Magnetic Resonance (NMR) spectroscopy is one of the most useful 
spectroscopic techniques to study IDPs in solution because it can provide information on the 
structure and dynamics with atomic resolution.
(76)
 The structural information can be obtained 
from many parameters in NMR, such as chemical shift, relaxation rates, line widths, spin-spin 
multiplet patterns, and residual dipolar coupling.
(77)
 NMR is based on the presence of nuclear 








 These nuclei 
have two possible spin states, which become split when an external magnetic field is applied. 
These nuclei can absorb electromagnetic radiation at a frequency that matches the energy 
difference between the two states. NMR can measure the resonance frequency and provide 
information on the local covalent and spatial arrangement of atoms, which depend on the 
chemical environment of resonating nuclei. NMR has been successfully applied to identify and 
characterize IDPs starting from the simplest NMR experiment, such as 1-D 
1
H NMR, to provide 
global structural information such as in the case of gliotactin.
(79)
 An example of 2-D NMR 
experiment is the heteronuclear single quantum coherence (HSQC)-based spectroscopy to 
provide residue-level information such as in the case of transcription factor ETS1.
(80)
 With a 2-D 
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NMR experiment, the chemical shift of various nuclei can be measured. The deviation of 








CO are sensitive to local secondary structure.
(81)
 The random coil states can 
be experimentally obtained using different denaturing conditions like 8 M urea.
(81)
 Other 
techniques have also been combined with NMR spectroscopy as a detection to study structure 




H nuclei, hydrogen exchange 
experiments in combination with NMR have been extensively used for the characterization of 
IDPs.
(76, 82)
 In a recent paper, a Bayesian approach has been developed to determine the structural 
ensemble of IDPs by extracting valuable information from NMR chemical shifts and J-coupling 
data.
(83)
 Although NMR has all the advantages mentioned above, NMR has also some limitations 
for IDP studies. One of the limitations is the high concentration requirement of the protein 
samples. Due to high structural flexibility, IDPs are more prone to aggregation at high 
concentrations.
(82)
 One other limitation is that using NMR experiments for studying large 
proteins can be challenging due to NMR signal overlap.
(84)
  
1.3 Disordered protein characterization by mass spectrometry 
 Mass spectrometry (MS) has emerged as a powerful tool for protein studies, which allows 
the investigation of the structure and the dynamics of proteins and their assemblies. The 
popularity of using MS evolved after the development of electrospray ionization (ESI)
(85)
 and 
matrix assisted laser desorption/ionization (MALDI).
(86)
 These ionization methods are considered 
“soft” ionization that can make ions out of biological molecules without causing fragmentation. 
Another advantage of ESI-MS is the ability to analyze protein mixture without prior purification 
steps as is required for other techniques, CD as an example. MS is also capable of analyzing 
large proteins, such as monoclonal antibodies
(87, 88)
 and viral protein complexes.
(89)
 In addition, 
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unlike NMR, MS can be utilized to analyze microliters of micromolar protein, which is of 
particular importance in the study of IDPs because IDPs are prone to aggregations at high 
concentrations.
(82)
 Several MS-based techniques to study IDPs are discussed in the following 
sections. I discuss MS techniques based on preservation of noncovalent interactions under 
electrospray conditions, such as charge state distribution analysis and ion mobility. These two 
techniques work under native MS conditions, in which the native protein conformation can be 
preserved during the ESI process, termed native ESI.
(90)
 The solvent for native ESI experiments 
should be compatible with the desolvation and ionization processes, and also should provide 
physiological conditions to preserve the protein native conformation. Solvent volatility and pH 
are two important properties for native ESI. Volatile buffer salts like ammonium acetate are 
usually used in the native ESI experiments.
(91)
 I also discuss MS techniques based on solution-
based labeling, such as hydrogen exchange and fast photochemical oxidation of proteins.      
1.3.1 Charge state distribution analysis 
For a pure protein, the typical MS spectrum consists of an envelope of signals where 
adjacent peaks represent ionization states differing by one charge, and the most intense peak is in 
the middle of the bell-shaped envelope. This envelope is referred to as the charge state 
distribution (CSD). Since CSDs are sensitive to the conformation held by proteins at the time of 
transfer to the gas phase, ESI-MS can be used to distinguish between ordered and disordered 
proteins by comparing their CSD profiles.
(92)
 Proteins with a lower degree of compactness tend 
to have a wider CSD because the number of charges incorporated will be higher.
(93, 94)
 Several 
factors need to be considered when designing ESI-MS experiments. These factors include 
solvent composition, pH, and effects of the source.
(92)
 IDPs may have different conformational 
ensembles at different pHs. One examples of an IDP which has been studied by ESI-MS charge 
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state distribution analysis is α-synuclein.
(95)
 α-synuclein is linked with Parkinson’s disease due to 
α-synuclein’s propensity to form intracellular aggregates.
(96)
 It has been found that α-synuclein 
populates four different conformations which coexist in solution.
(95)
 Each of these conformations 
has a different extent of disorder as identified by ESI-MS.   
1.3.2 Ion mobility 
 One of the native ESI-MS techniques to study protein conformations is ion mobility (IM) 
coupled to ESI-MS. This technique allows distinguishing different conformers among ions of 
same mass/charge ratio (m/z) and can help reduce the spectral complexity of complicated protein 
mixtures in the gas phase.
(94)
 The separation is based on a combination of cross-sectional area 
and m/z, in a chamber filled with a known gas (helium) at a known pressure across which is 
applied a weak static electric field.
(97)
 The time required for the ions to travel through a cell is 
directly affected by the ion size and shape. Therefore, how quickly gas phase ions travel through 
the cell under the influence of the electric field can be measured and provide valuable 
information about the conformation and compactness of proteins.
(97, 98)
 IM coupled to ESI-MS 
has been used to study several IDPs.
(99-101)
 One of these IDPs is tumor suppressor protein, p53, 
which is known to bind to DNA.
(102)
 The p53-DNA complex is stabilized by a zinc ion which 
plays a role in the p53 binding ability to DNA.
(103)
 IM-MS has been used to investigate the 
conformational change of p53 caused by zinc.
(104)
 Unfolded conformers have been detected in 
p53 in the absence of zinc when IM data are compared to the data of p53 in the absence of zinc. 
Although IM-MS can provide valuable information about IDPs, the technique still has some 
limitations. One of the limitations is in the mechanism of transferring ions from the solution 
phase to the gas phase for IDPs which may affect the actual native conformations of IDPs. IDPs 
become highly charged during ESI, which in turn increases the likelihood of forming extended 
18 
 
conformations due to electrostatic repulsion.
(99)
 This electrostatic repulsion may disrupt any 
residual structure present within an IDP. Therefore, IM-MS may not be able to detect such 
residual structuring in IDPs in such cases. In addition, without complementary experiments, 
native ESI and IM-MS cannot provide localized information about folded or unfolded states in a 
protein.                   
1.3.3 Amide hydrogen exchange 
Hydrogen exchange (HX) has become a powerful method to study protein conformation 
and dynamics. This method is based on monitoring the exchange by protein backbone amide 
hydrogens with deuterium atoms from the solvent surrounding the protein.
(105, 106)
 The amide 
hydrogens exchange with deuterium at reaction rates that can be measured experimentally. 
Several techniques have been used to monitor hydrogen exchange kinetics in proteins. These 




 and most recently mass 
spectrometry.
(109)
 Hydrogen exchange coupled to mass spectrometry (HX-MS) has shown 
promise for analysis of proteins with high sensitivity, low sample requirement, and the ability to 
analyze large proteins and protein complexes.
(110, 111)
 During the hydrogen exchange experiment, 
aliphatic hydrogens in proteins do not exchange to any measurable extent.
(105)
 The deuterium 
exchange by side-chain (except for histidine) and N/C-terminal hydrogens will be very rapid, but 
the deuterium signature will not be retained in subsequent quenching and chromatography steps 
in a typical HX experiment.
(105, 106, 112)
 The rate of amide HX is a function of the structure and 
dynamics of the protein because the exchange is highly dependent on hydrogen bonding and 
solvent accessibility.
(113)
 Highly flexible regions will exchange more rapidly, while rigid regions 
exchange more slowly.
(113, 114)
 Different HX experimental strategies have been used for 
investigating structure and dynamics in different protein and protein complexes. Using HX-MS, 
19 
 
proteins can either be studied intact or can be digested by proteolysis for local structural analysis. 









 and methyl CpG-binding protein 2.
(118)
 
Since the research presented in the following two chapters utilizes HX-MS to study IDPs, a more 
in depth overview of HX-MS is presented next. 
1.3.3.1 Fundamentals of hydrogen exchange 
 Amide HX in the absence of any higher order structure is referred to as chemical 








] + kw[H2O]    (1) 
where kA, kB, and kw are the rate constants for acid-, base-, and water-catalyzed amide deuterium 
exchange reaction, respectively. The rate constants, determined for a random coil-like poly-DL-



















 It is obvious that the rate of base catalysis exceeds the 
acid and water catalysis. Due to its low value, sometimes the water-catalyzed exchange is 
omitted from equation 1. The chemical exchange rate constant is highly dependent on pH, 
temperature, the identity of the amino acid residue and its neighboring side chains, and solution 
composition such as salt contents.
(112)
 The chemical exchange rate is predominantly base-
catalyzed above pH 3.0 and predominantly acid-catalyzed below pH 2.3. The rates of acid- and 
base-catalyzed exchange are equal at pH 2.5-3.0 (pHmin).
(121)
 The chemical exchange rate 






 Proteins in solution exists as an ensemble of interconverting conformations.
(122)
 
Therefore, each amide hydrogen in a protein may exist in folded and unfolded conformations at 
any point in time. The mechanism of HX usually described by the Linderstrom-Lang model.
(105, 
123)
 The mechanism is illustrated in equation 2.  
       (2) 
Each amide hydrogen is in dynamic equilibrium between two states: “closed” (exchange 
incompetent) and “open” (exchange competent). Breathing motions in proteins can transiently 
break hydrogen bonds in exchange incompetent state NHclosed, which exposes the exchangeable 
site to exchange with deuterium from the solvent at a rate defined by the chemical rate of 
exchange, kch.
(124, 125)
 The frequency at which a residue will enter the exchange competent state 
NHopen will depend on the opening rate, kop, before returning into the NHclosed state with the 
closing rate, kcl. The observed hydrogen exchange rate for each residue, kobs, which is the 
measured rate of deuterium loss or incorporation, can be expressed as follows:
(126)
 
   𝑘obs = 
𝑘ch𝑘op
𝑘cl+𝑘ch+𝑘op
     (3) 
The equation 3 can be rewritten as follows if the amide is assumed to be mostly in the closed 
state, where kop << kcl:
(126, 127)
 
   𝑘obs ≅ 
𝑘ch𝑘op
𝑘cl+𝑘ch
    (4) 
The approximation in equation 4 always applies for folded proteins. Depending on the relative 
rates of the exchange and conformational transition in a protein, two distinct regimes, EX1 and 
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   𝑘obs,EX2 =
𝑘op
𝑘cl
 𝑘ch   (5) 
The kinetic limit under EX2 mechanism implies that the opening and closing of a hydrogen bond 
occurs many times before exchange actually occurs. From the equation 5, the protection factor, 
the ratio between chemical and observed exchange rates, can be measured. Measured kinetics of 
exchange under EX2 condition can offer a direct link to the free energy variation associated to 
local unfolding of a protein as described in equation 6:
(126)
 
   ∆𝐺𝑢






   (6) 
Where R is the gas constant and T is the absolute temperature. If the exchange is being monitored 
by MS, the characteristic of EX2 exchange will show a gradual increase in m/z of a peptide 
segment as a function of labeling time.
(126)
  
The mechanism of exchange is referred to as EX1 when the structure closing step 




  𝑘obs,EX1 = 𝑘op        (7) 
Under The EX1 limit, the deuterium exchange is much faster than conformational changes. 
There are few proteins that exchange by an EX1 mechanism under native conditions. If the 
exchange is being monitored by MS, the characteristic of EX1 exchange will show two distinct 
mass spectral envelopes on the m/z scale.
(126)
 Two mass spectral envelopes will be observed 
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because kop << kcl and kcl << kch, which results in complete labeling of all exchangeable sites 
within a given protein at every opening event. As a function of labeling time, the intensity of the 
two envelopes changes, but not their positions on the m/z scale. In addition, as a function of 
time, a simultaneous decrease in the intensity of the unlabeled envelope and increase in the 
intensity of the labeled envelope will be observed.     
1.3.3.2 HX experimental design and workflow 
 Protein HX reactions are typically performed at neutral or near-neutral pH. Mainly, there 
are two kinds of experimental schemes for HX labeling: pulse and continuous labeling.
(128)
 In 
pulsed HX labeling, a protein is exposed to deuterium for a brief and constant time interval 
followed by transfer to quenching conditions (0 °C and pH around 2.5, where the chemical 
exchange rate is at minimum). Pulse labeling allows kinetic monitoring of folding and unfolding 
transitions.
(128)
 For example, a folded protein can be introduced to a solution that has denatured 
promoting compositions. On the other hand, in continuous HX labeling, the protein is transferred 
to a deuterated solution for different lengths of time followed by transfer to quenching 
conditions. The labeling time for continuous labeling experiments can be various depending on 
the stability of intramolecular amide hydrogen bonds and solvent accessibility in a protein.
(126, 
128)
 Slowly exchanging regions will require longer exposure times to reach a deuterium 
maximum, but faster exchanging regions will require shorter exposure times to reach deuterium 
maxima. The rapid exchange of protein regions at neutral pH and 25 °C may indicate the 
presence of highly flexible or unstructured regions. Since continuous HX labeling uses different 
labeling time points (ranging from seconds to hours), the probability of detecting differences 
between two or more protein states is more likely. This property makes the continuous labeling 
experiments more widely applicable than the pulsed labeling experiments. 
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 A schematic representation of a typical continuous HX-MS experimental workflow to 
analyze the local conformation of a protein in two states is shown in Figure 1.4. In the first step, 
the protein sample (panel A) is incubated in an excess amount of D2O buffer for different 
amounts of time ranging from seconds to hours (standard time points) for a typical HX labeling 
experiments. Using the standard time points to study IDPs can be difficult because of several 
factors. One of the factors is the fast exchange that the majority of peptides will show in a largely 
unstructured protein, which makes these peptides reach deuterium maxima at the fastest time 
points of the standard labeling. Several developments have been made to the conventional HX 
experiment to probe the conformation and dynamics of IDPs. One of the methodological 
developments is the labeling of protein at millisecond time points.
(129, 130)
 In the following 
section, an experimental design for millisecond HX experiment will be presented. 
 
Figure 1.4. Schematic representation of continuous-labeling of the HX-MS experimental 
workflow. See the text for description of each step in the workflow.  
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 In the next step of the HX experiment as shown in Figure 1.4, the labeled sample (panel 
C) is quenched by lowering the temperature to 0 °C and reducing the pH of the final mixture to 
2.5. Reducing the pH can be achieved by adding of concentrated acid like hydrochloric acid, 
formic acid, or a strong buffer like phosphate. The rate of forward reaction (amide H to D) slows 
down by several orders of magnitude at quenching conditions.
(112, 131)
 In the next step of Figure 
1.4, to obtain the local structural information of at the peptide level, the quenched protein sample 
(panel D) is digested using an acid resistant protease like pepsin. The protein digestion can be 
achieved by either performing online pepsin digestion using an immobilized pepsin column
(132, 
133)
 or using in solution digestion with maintaining the quench conditions. The online digestion 
can offer a higher efficiency of digestion than in-solution digestion.
(132)
 The digested peptides 
(panel E) can then be concentrated and desalted on a reversed-phase peptide trap. The peptides 
are separated using reversed-phase high performance liquid chromatography (HPLC). Then, the 
peptides are infused into a mass spectrometer through an ESI source for peptide mass analysis. 
Following data acquisition by the mass spectrometer, the identity of each peptide at different 
labeling time points and for each condition can be obtained (panel F). The deuterium 
incorporation at each time point can then be converted to an uptake plot to compare the kinetics 
of exchange for each peptide of the protein at a specific state with other states of the protein. 
 Several parameters can affect the total deuterium uptake for each peptide. One of the 
parameters is back exchange (D to H) during the quench step and subsequent chromatography 
steps.
(109)
 During these steps, the H2O based solution will add H2O to the reaction mixture, which 
introduces new equilibrium conditions that leads to deuterium loss from the peptides. It is 
important to minimize back-exchange because higher deuterium loss causes loss of valuable 









 deuterium-to-sample ratio, and solution additives such as denaturants
(134)
 
during HX experiments play critical roles in controlling of back exchange. The steps to reduce 
back exchange include the use of refrigeration or ice baths to control temperature during 
chromatography, use of acid additives in the mobile phase to slow down the back exchange 
process, and the type of acid additive in the LC system. In order to determine the back exchange 
percentage in an HX experiment, a control experiment will be required. The control experiment, 
a fully deuterated control, can be prepared by labeling protein or peptides with D2O for a much 
longer time than typical HX experiment. The control experiments will provide correction factors 
accounting for back exchange.
(135)
  
1.3.3.3 Quench-flow apparatus for millisecond HX-MS 
 The labeling times in conventional HX experiments are in the range of seconds to hours, 
but using this time range to provide important information about the dynamic behavior of the 
most IDPs can be difficult. At physiological conditions, amide hydrogens in IDPs exchange at 
rates that are near to their chemical exchange rates. The rapid exchange of the IDP segments 
makes these peptides reach deuterium maxima at the fastest time points of the standard labeling 
time (usually around 10 s). Several developments have been made to the conventional HX 
experiment to characterize weakly structured regions of proteins or intact IDPs. Keppel and Weis 
developed an off-line quench-flow system for analysis of disordered proteins.
(129)
 The labeling 
time is in the range between 42 to 5000 ms. A schematic depiction of the quench-flow system is 
shown in Figure 1.5. Three syringes deliver sample carrier (H2O buffer, syringe 1 with 1 ml 
volume capacity), label (D2O buffer, syringe 2 with 5 ml capacity), and quench (syringe 3 with 5 
ml capacity). To maintain stable flow regardless of back pressure, all three syringes are driven by 
a single syringe pump. The connections are made with fused silica capillaries connected to the 
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three syringes with a special adapter to prevent leaks at high flow rates. The protein sample is 
introduced to the system using an electronically actuated six-port HPLC valve. The protein 
sample can be labeled with D2O buffer at 1:5 (v:v) ratio at labeling mixer 1. To achieve a good 
mixing efficiency between the sample and D2O buffer, a thinner fused silica internal diameter 
(ID) between the valve and T mixer 1 has been used. The two flows, sample (F1) and label (F2), 
are mixed at an angle of 180°. The resulting reaction mixture exits through mixer 1 and is labeled 
through a delay line with a known length and ID. The reaction time, trxn, has been determined 
from the mathematical relationship between the delay line volume, Vd (determined from delay 
line length, L, and inner radius, rd), and total flow rate, F1+F2, as shown in equation 8:
(129)
 
   𝑡rxn  =  
𝑉d
𝐹1+ 𝐹2




   (8)   
By changing the flow rates, labeling times between 42 and 5250 ms have been achieved. The 
labeled sample is mixed with quench, delivered by syringe 3, in mixer 2 at an angle of 180°. The 
quenched sample exits mixer 2 and is immediately flash frozen in a microcentrifuge tube 





Figure 1.5. Schematic depiction of a setup for millisecond HX. See the text for more details on 
the setup overview. Redrawn from Ref. (129).   
     
1.3.4 Hydroxyl radical protein footprinting 
 Another MS-based approach to investigate protein conformation and dynamics is 
hydroxyl radical protein footprinting. Hydroxyl radical, which can be generated by different 
methods, probes solvent accessibility of amino-acid side chains by oxidizing them.
(136)
 The side 
chain modifications are irreversible and maintained throughout the following proteolysis and 
LC-MS/MS experiment.
(137)
 These modifications result in mass shifts, which can be easily 
detected by MS and then by comparing the masses to unmodified forms of the protein. With 
hydroxyl radical footprinting, a change in solvent accessibility of a protein between two or more 
states can be determined.
(136, 137)
  To localize the specific sites of oxidation, tandem mass 
spectrometry (MS/MS) methods should be used. Therefore, the structural resolution of hydroxyl 





1.3.4.1 Methods of generating hydroxyl radical 
 There are several methods for generating hydroxyl radicals to oxidize side chains. 
Detailed information about generating hydroxyl radical has been thoroughly reviewed.
(138)
 One 
of the methods is Fenton chemistry.
(139)
 This method is based on producing hydroxyl radical at 
slower rates, and this method can be used for experiments that use longer hydroxyl radical 
exposure times (5-30 s).
(136, 139)
 The hydroxyl radicals in this method are produced from 
hydrogen peroxide by oxidizing EDTA-chelated Fe(II) to Fe(III). This method has become a 
standard method for studying DNA and RNA interactions because it allows for the 
stoichiometric generation of hydroxyl radical from Fe(II) and H2O2 without Fe (III) precipitation 
concerns. Another method of generating hydroxyl radical is synchrotron radiolysis of water. This 
method is based on radiolysis of water with X-ray photons.
(140)
 As a result of the ejection of an 
electron from water, this high energy electron ionizes other water molecules, and ultimately 
generates hydroxyl radicals and other less reactive products. Generally, synchrotron radiolysis of 
water method generates a relatively high yield of hydroxyl radicals and can be used for 
experiments that use very short labeling times (10-200 ms).
(136, 140)
 This method has been applied 
to footprinting DNA-protein interactions and large proteins. One of the advantages of this 
method is that there is no need for additives to produce hydroxyl radicals because water is the 
source of hydroxyl radical. Ultraviolet (UV) photolysis of hydrogen peroxide is another method 
to generate hydroxyl radicals.
(141)
 UV light can homolytically cleave H2O2 to produce hydroxyl 
radicals. The hydroxyl radical exposure time using this method depends on the light source. It 
can be microseconds using laser sources or it can be as long as hours using UV lamps.
(136)
 
Although there are several methods to produce hydroxyl radicals, the results of oxidative 
chemical modifications are generally independent of the technique used for radical production. 
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While hydroxyl radicals are non-specific reactants, they do not label sidechains with equal 
efficiency. Hydroxyl radicals have been shown to react with 14 of the 20 naturally occurring 
amino acids.
(136)
 These residues are Cys, Met, Trp, Tyr, Phe, His, Leu, Ile, Arg, Lys, Val, Ser, 
Gln, and Glu. The rate constant of the reactions range from 1.7 × 10
7









The hydroxyl radicals can also lead to nonspecific cleavage reactions of protein backbones, but 
this cleavage reaction occurs at rates 10-1000 times slower than side-chain oxidation.  
1.3.4.2 Fast photochemical oxidation of proteins 
 Fast photochemical oxidation of protein (FPOP) is a method of hydroxyl radial 
footprinting that uses a pulsed KrF laser shot (248 nm) to generate hydroxyl radicals by 
photolysis of hydrogen peroxide (equation 9).
(142, 143)
 
  H2O2 
                    ℎ𝑣                   
→                2 ·OH   (9) 
The protein solution mixed with hydrogen peroxide and a dissolved hydroxyl scavenger like 
glutamine flows through a fused silica capillary. The protein sample is irradiated by a KrF 
excimer laser at a frequency that ensures all sample protein is irradiated once, but for a 
measurable exclusion fraction (see Figure 1.6). Figure 1.7 shows a schematic representation of 
FPOP experimental workflow for a protein hydroxyl radical labeling. Due to the presence of 
glutamine in the solution, the concentration of hydroxyl radical falls by 50,000-fold in under 1 
microsecond, according to pseudo-first order analysis of hydroxyl radical consumption.
(142)
 This 
timescale of labeling limits the oxidation to surface exposed side chains. This timescale is also 
faster than most protein unfolding events, so the labeling-perturbed conformations of protein are 
not sampled.
(142, 143)
 The modified peptides can then be quantified using mass spectrometry after 
proteolysis of the modified protein sample. Although there are many pathways for hydroxyl 
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radical-mediated labeling on residue sidechains, the most common net mass shift is the 
increments of +15.9949 Da incorporation of oxygen in equilibrated solutions.
(144)
 Different 
oxidation products of the peptides lead to a challenging task for data analysis. It is very difficult 
to do data analysis without using computational analytical tools. Several computational tools 
have been developed to meet the needs of covalent labeling experiments. One of the 
computational analytical tool is ProtMapMS.
(145)
 The liquid chromatography elusion profile for 
each peptide can be automatically obtained using ProtMapMS. FPOP experiments have some 
advantages over HX experiments. One of the advantages in FPOP experiments is irreversible 
labeling of the peptides. Therefore, the FPOP experiments do not require specialized LC-MS-
based strategies to preserve the label. Residue level resolution can be achieved by a tandem MS 
with FPOP experiments with no concern about gas-phase scrambling of the label, but label 
scrambling is problematic for HX experiments.
(136)
 Since FPOP experiments probe only 14 out of 
the 20 amino acid side chain as mentioned above, FPOP experiments cannot be useful for 
proteins enriched in non-reactive amino acid residues. However, HX experiments can probe all 
amide backbone hydrogen, except proline. Since FPOP experiments probe side chains and HX 
experiments probe backbone amide hydrogens, the FPOP method can serve as a complementary 




Figure 1.6. Schematic of the FPOP reaction region with typical settings. The laser beam 
intersects the fused silica flow tube (150 µm inner diameter). The frequency of laser beam and 
the flow rate are synchronized to insure that the protein is only exposed once to hydroxyl 
radicals. The synchronized flow and frequency of laser provide an exclusion region between two 
irradiated plugs.     




Figure 1.7. Schematic representation of the FPOP experimental workflow for a protein. In the 
first step, a protein sample is mixed with hydrogen peroxide and a hydroxyl radical scavenger 
like glutamine immediately prior to the infusion. In the next step, the protein sample is labeled 
with hydroxyl radicals that are generated by pulsed KrF excimer laser shots (248 nm). The next 
step is protein digestion using trypsin. The tryptic peptides are then injected into the LC-MS/MS 
system, and then analyzed by a mass spectrometry. The data obtained from LC-MS/MS contains 
the total ion chromatograms, extracted ion chromatogram, and mass spectra for all peptides. In 
the final step, the fraction of modification for each peptide can be calculated, and residue-level 
resolution can be achieved by MS/MS data analysis for each peptide.   
 
1.4 Overview of the dissertation 
 Due to important roles of IDPs in cells, it is essential to develop new methods to study 
conformational dynamics of IDPs. Over the past two decades mass spectrometry has become a 
powerful technique for biophysical characterization of proteins due to its high sensitivity and 
variety of choices for sample preparation and instrumentation. The purpose of this dissertation is 
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to demonstrate the application of MS-based approaches to study IDPs. Here I present the 
application of two important mass spectrometry-based approaches: hydrogen exchange and fast 
photochemical oxidation of protein to characterize two disordered protein systems calcineurin 
and ACTR/CBP, respectively. This research was also conducted to make improvements to HX-
MS methods for IDPs studies. The following chapters discuss the advantages of using these two 
MS-based techniques in the applications of complicated IDP systems. 
 Calcineurin plays essential roles in processes such as T-cell activation, neuronal and 
muscle development, and cardiac hypertrophy. In its inactive state, an autoinhibitory domain is 
bound in the active site. At high calcium concentration, calmodulin binds calcium ions, resulting 
in calmodulin binding to the unstructured regulatory domain of calcineurin. Calmodulin binding 
causes release of the autoinhibitory domain from the active site, activating calcineurin. To better 
understand the mechanism of activation, it is important to look at the complete complex. To 
identify conformational and dynamic changes in calcineurin induced by calmodulin, HX-MS has 
been used. The HX-MS data for calcineurin is discussed in the chapter 2. The results are 
presented from all regions of the CaN A and B chains to describe the mechanism of CaN 
activation. A new model of CaN activation upon CaM binding is discussed. 
 Millisecond HX can be a very useful technique to characterize IDPs because most of the 
exchange occurs on this timescale at room temperature and near neutral pH. Protection in HX 
experiments, which is a measure of the slowing of exchange caused by structure, can reveal 
information about protein structures. The degree of protection can be directly related to the 
degree of structure if the observed rate of HX is compared to the rate of HX by an amide in an 
unprotected reference state. Without an unprotected reference state, it is impossible to estimate 
such protection because the unprotected reference state is an essential part in measuring 
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protection. Generally, chemical exchange, calculated using an empirical formula based on 
unstructured model peptides, is used as an unprotected reference state. Our lab and others have 
found that the calculated chemical exchange does not seem to be accurate enough to be used as 
an unprotected reference state in weakly protected IDPs. In the chapter 3, different approaches to 
prepare an unprotected reference state for quantifying the degree of structure in IDPs are 
explored. ACTR and CBP were used as model IDPs to explore the best approach to produce an 
unprotected reference state for millisecond HX.  
 ACTR and CBP are a useful model system for conformational analysis of IDPs. On their 
own, CBP is a mostly helical molten globule while ACTR is near-random coil. The proteins bind 
with high affinity to form a well-defined complex with three helices each. Our previous work 
showed that HX can provide important information about IDPs, but labeling takes place on the 
millisecond-second timescale. Since protein folding is slower than microseconds, FPOP might 
reveal states of IDPs that are undetectable by HX. Chapter 4 discusses the application of FPOP 
method to characterize IDPs. This chapter also discusses how FPOP method can serve as a 
complementary method to HX in the study of localized disorder regions in IDPs. 
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Mechanism of calmodulin-induced activation of calcineurin 




Calcineurin (CaN) is a heterodimeric serine/threonine phosphatase activated by calcium 
and calmodulin (CaM) binding.
(1-4)
 CaN plays essential roles in various cellular and biological 
processes such as T-cell activation, muscle contraction, neuronal signaling, and cardiac 
growth.
(3)
 At high calcium concentration in the cell cytoplasm, calcium ions activate calmodulin, 
resulting in calmodulin binding to CaN and causing to CaN activation.
(5)
 One of the common 
substrates of CaN is the nuclear factor of activated T cells (NFAT) family of transcription 
factors.
(6, 7)
 CaN binds directly to NFAT, leading to dephosphorylation of NFAT. The 
dephosphorelation is followed by translocation of NFAT into the cell nucleus, resulting in DNA 
transcription.
(7, 8)
 CaN dysregulation has been linked to a number of major diseases such as 
Alzheimer’s disease and Down’s syndrome.
(9, 10)
 Due to its role in many biological processes, 
CaN has been the target for two immunosuppressant drugs, tacrolimus (FK506) and cyclosporine 
A (CsA).
(11-14)
 FK506 and CsA bind tightly to the abundant intracellular proteins FKBP12 and 
cyclophilin A, respectively, resulting in activation of these proteins. These drug-protein 
complexes then inhibit CaN activation in the cell by directly binding to CaN. 
CaN is a heterodimer composed of two subunits: calcineurin A chain (CaN A) with 
molecular mass of 59 kDa and calcineurin B chain (CaN B) with a mass of 19 kDa.
(15)
 The 
ribbon diagram of CaN structure from PDB entry 1AUI
(16)
 is shown in Figure 2.1b. Human CaN 
A has three isoforms (α, β, and γ) and CaN B has two isoforms (1 and 2).
(17)
 α and β CaN A are 
the two main isoforms that bind to a common CaN B1 isoform. α CaN is the most dominant form 
in neurons, the βCaN isoform is broadly distributed, and the γ isoform binds to a testis-specific 
CaN B2 isoform. Based on biochemical and genetic studies, four distinct functional domains of 
CaN A have been identified.
(18, 19)
 Figure 2.1a shows the domain organization of the CaN A. The 
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domains are a catalytic domain, a CaN B-binding domain (CaNBBD), a calmodulin-binding 
domain (CaMBD), and an auto-inhibitory domain (AID). Together, the calmodulin-binding 
domain and the AID comprise the regulatory domain (RD) of the CaN A chain. Except for a 
short ordered helix of the AID, all parts of the regulatory domain are absent in the electron 
density map of αCaN A (PDB: 1AUI).
(16)
 Figure 2.1b shows the entire CaN molecule including a 
model of the disordered regulatory domain. Within the CaN A catalytic domain there are a zinc 
and an iron atom that are part of the catalytic active site. CaN B, which has 35% sequence 
identity with calmodulin, consists of two lobes with two calcium ions bound by EF-hand motifs 




Figure 2.1. (a) Domain organization of the αCaN A chain and (b) structure of human α-
calcineurin (CaN). The depiction of CaN structure is modified from PDB entry 1AUI.
(16)
 The 
CaN A and CaN B are colored in yellow and orange, respectively. The autoinhibitory domain is 
shown in pink. The disordered regulatory domain is shown in green. The calmodulin binding 
domain is shown in blue. The disordered regulatory domain, which is absent from the crystal 
structure, was modeled with PyMOL (Schrödinger LLC, Portland, OR, USA). 
 
Depending on the calcium concentrations in the cell, CaN undergoes sequential 
conformation changes to become fully activated.
(15)
 Several models of CaN activation have been 
proposed, and a widely accepted model of activation is explained here.
(5, 15)
 At low calcium 
concentrations, CaN exists in an inactive state in which only the high-affinity calcium binding 
site of CaN B is occupied with calcium. In addition, the AID and the calmodulin-binding domain 
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remain associated with the active site and the CaN B-binding domain, respectively.
(5)
 At high 
calcium concentration in the absence of CaM, calcium binds the low-affinity sites on CaN B, 
resulting in the dissociation of a major part of CaN regulatory domain including the calmodulin-
binding domain causing CaN to become partially active. At high calcium concentration and in 
the presence of CaM, CaM binds four calcium ions and then binds to the calmodulin-binding 
domain of CaN. This binding causes an ordering in the regulatory domain that removes the AID 
from the CaN active site, turning CaN into a fully active state.
(20, 21)
 Many techniques have been 












 and hydrogen exchange.
(21, 26)
 Some of the studies are based on low-resolution 
techniques to characterize truncated forms of CaN where the regulatory domain sequence is 
absent from the structure. Some other studies are only based on high-resolution techniques to 
describe the regulatory domain to probe the CaN structural changes. None of the high-resolution 
techniques have been used to describe the CaN structural change in solution using full length 
CaN. In addition, working with the truncated forms of proteins sometimes is inadequate because 
they may not reliably represent how full-length forms undergo conformational change. Thus, 
more structural information about conformational changes in solution is required to fully 
understand the mechanism of CaN activation. 
Our previous work on the regulatory domain-autoinhibitory domain-C-terminal domain 
(RD-AID-CT) construct isolated from full length CaN showed that the regulatory domain and 
AID are completely disordered at high calcium concentration in the absence of CaM.
(21)
 At high 
calcium concentration in the presence of CaM, two regions of the regulatory domain become 
structured. The calmodulin-binding domain becomes tightly structured. The region located to the 
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C-terminal side of calmodulin-binding domain becomes weakly structured. The data suggested 
that the structuring of the two regions of the regulatory domain causes displacement of the AID 
from the active site, but CaM has no effect on the AID, which remains unstructured. Therefore 
the AID must become structured only when it binds to the active site. To better understand the 
mechanism of activation, studies on full-length CaN in solution are required. Recently, there has 
also been considerable debate about the stoichiometry of CaN-CaM complex.
(24, 25, 27)
 The 
questions of whether there is a second weak CaM binding site in the regulatory domain of CaN 
and what is the binding ratio of the complex in solution need to be addressed. 
Hydrogen exchange (HX) mass spectrometry can provide vital information about protein 
structural changes in solution at peptide level resolution. This technique is based on labeling the 
backbone amide hydrogens of a protein with deuterium. The rate of exchange is a function of the 
structure and dynamics of the protein because the exchange is highly dependent on hydrogen 
bonding and solvent accessibility.
(28, 29)
 Highly flexible regions will exchange more rapidly, 
while rigid regions exchange more slowly.
(28)
 Protection in HX experiments, which is a measure 
of the slowing of exchange caused by structure, can reveal information about protein structures. 
In this work, we used full-length CaN to understand the mechanism of CaN activation upon 
calmodulin binding in the presence of Ca
2+
. The results with full-length CaN demonstrate that 
the calmodulin-binding domain of the regulatory domain is completely disordered in the absence 
of CaM, while it folds tightly upon binding to calmodulin in the presence of excess of Ca
2+
. This 
result confirms our previous work on isolated RD-AID-CT.
(21)
 However, using full-length CaN, 
we did not observe any weak protection in the region adjacent to the C-terminal side of the 
calmodulin-binding domain. Our data also reveal that a region in the regulatory domain that is 
immediately adjacent to the N-terminal side of the AID becomes weakly protected. Additionally, 
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we have observed CaM-induced increase in flexibility in segments located near the CaN active 
site. The observed HX kinetics also show that some segments of the B chain become protected 
upon calmodulin binding. The data suggest that calmodulin, which binds to the regulatory 
domain in the CaN A, may interact with the CaN B and the N-terminal side of the AID. Finally, 
and most surprisingly, we found no changes in the structuring of the CaN AID upon CaM 
binding. We present results from all regions of the CaN A and B chains to describe the 
mechanism of CaN activation. We also propose a new model of CaN activation upon CaM 
binding. In a separate HX experiment, we also explore several possible binding ratios of CaN to 
CaM using HX mass spectrometry on the isolated RD-AID construct from CaN. We confirmed 
that the stoichiometry of CaN:CaM binding in solution is 1:1.  
2.2 Materials and methods 
2.2.1 Materials 
Calcium chloride, porcine pepsin, deuterium oxide (D2O) (99.9% D), DL-dithiothreitol 
(DTT), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and sodium chloride were 
purchased from Sigma (St. Louis, MO). LC-MS grade formic acid (99+ %) and water used in 
chromatography were purchased from Fisher Scientific (Hanover Park, IL). Pre-mixed 0.1% 
formic acid in acetonitrile (v/v) was purchased from Honeywell VWR (Arlington Heights, IL). 
Sodium hydroxide and hydrogen chloride were both from Fisher Scientific. 
2.2.2 Protein expression and purification 
Full-length human α calcineurin (CaN), a truncated regulatory domain-autoinhibitory 
domain-C-terminal construct (RD-AID-CT), and human calmodulin (CaM) were gifts from Prof. 
Treavor Creamer (University of Kentucky). All the proteins were expressed and purified as 
described previously.
(21)
 Briefly, CaN was expressed from a pETagHisCN expression vector 
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containing CaN A (with N-terminal His6 tag) and B1 genes in Escherichia coli BL21 (DE3) 
CodonPlus RIL cells. The RD-AID-CT construct was expressed from a pET303/CT-His 
expression vector containing a gene for the human sequence RD-AID-CT in Escherichia coli 
BL21 (DE3). Both proteins were purified by using a Ni-NTA column followed by a CaM-
Sepharose
(30)
 column. Calmodulin was expressed from a pETCaMI expression vector in 
Escherichia coli BL21 (DE3). After expression, CaM was purified on a 2-triflouromethyl-10-
aminopropyl phenothiazine-Sepharose column.
(30)
 Protein concentrations of CaN (13.9 µM), 
RD-AID-CT (20.3 µM), and CaM (100 µM) were determined using a BCA assay
(31)
 
standardized with BSA (Thermo Fisher Scientific). The identity of each protein was confirmed 
by intact mass spectrometry measurements. 
2.2.3 Reduction of calcineurin B-dimerization and enzyme kinetics 
 In the mass spectrum of CaN, we observed both monomeric B at 19168.6 Da (theoretical 
mass of 19168.7 Da) and a dimer at 38335.6 Da consistent with a disulfide-bonded dimer 
(theoretical mass of 38335.4 Da)(see deconvoluted spectra in Figure 2.S1). Since CaN B was not 
supposed to have disulfide bonds because it has two cysteines in the form of free thiols 
(16)
, we 
used DL-dithiothreitol (DTT) to reduce CaN B dimerization. This step was necessary to make 
the protein ready for hydrogen exchange analysis. The intact CaN (0.4 µM) was prepared in two 
buffers, one without DTT as a control (20 mM HEPES, 100 mM NaCl, 10 mM CaCl2, pH 7.5) 
and the other with DTT (5 mM DTT, 20 mM HEPES, 100 mM NaCl, 10 mM CaCl2, pH 7.5). 
CaN was incubated in DTT for 15 min, 40 min, and 2 h at 4 °C in a thermostated block (IC20 
Ecotherm Heating/Chilling Plate, Torrey Pines Scientific, La Jolla, CA). The samples were then 
loaded onto an HPLC system (Agilent 1200 series) combined with time-of-flight mass 
spectrometer (Agilent 6220, Santa Clara, CA, USA). The mobile phases were 0.1% formic acid 
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(A) and 90% acetonitrile/10% water/ 0.1% formic acid (B). The CaN A, CaN B, and dimer of 
CaN B were trapped and desalted on a C4 trap (Jupiter C4 self-packed 1 mm × 10 mm cartridge, 
Phenomenex, Torrance CA) for 3 min at 200 µL/min A followed by separation on a C4 column 
(Jupiter 4u Proteo 90 A°, 4 micron, 1 × 50 mm) using a gradient 15-60% B over 20 min at 50 
µL/min. To monitor the reduction of CaN B dimer and increasing the intensity of monomer CaN 
B, we compared the area under the peak of extracted ion chromatogram (EIC) of 913.78 m/z 
with 892.50 m/z which correspond to monomer CaN B [M+21H]
21+
 and dimer CaN B 
[2M−2H+43H]
43+
, respectively (see mass spectra in Figure 2.S1). The data summarized in Table 
2.1 show that the amount of CaN B dimer decreases by increasing the protein incubation time in 
DTT. Since we were using 5 mM DTT as a reducing agent, we wanted to compare the CaN 
enzymatic activity under non-reducing with reducing conditions. This comparison was necessary 
to confirm that DTT did not damage the enzymatic activity of CaN. A CaN activity assay was 
then performed by our collaborators in the Trevor Creamer lab (University of Kentucky). The 
activity was assayed using p-nitrophenyl phosphate (pNPP) as the substrate. The assay was 
performed with CaN diluted in the assay buffer (50 mM Tris pH 7.5, 100 mM NaCl, 6 mM 
MgCl2, 0.5 mM DTT, 0.025-40% pNPP, 0.5 mM CaCl2) and with CaN in the same buffer but 
with a 40 min preincubation in 5 mM DTT. The reactions were performed at 37 °C. The 
absorbance of the reactions at 405 nm was measured immediately and after 2, 5, 10, 20, 30, 40 
minutes. According to the assay, the activity of CaN in the absence of DTT is comparable to 
CaN in the presence of DTT in the buffer even after 40 min of the enzyme-substrate reaction (see 
Figure 2.2). Since we preincubated CaN in DTT for 40 minutes for the activity assay and showed 
no difference in activity without the added DTT, we proceeded to incubate CaN in 5 mM DTT 
for 40 min before hydrogen exchange experiments. 
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Table 2.1. Reduction of calcineurin B-dimerization using dithiothretol (DTT). The intact CaN 
sample was prepared in two buffers, one without DTT as a control (20 mM HEPES, 100 mM 
NaCl, 10 mM CaCl2, pH 7.5) and the other with 5 mM DTT in the same buffer. CaN was 
incubated in DTT for 15 min, 40 min, and 2 h at 4 °C to determine the effective condition to 
reduce CaN B dimer. The EIC of 913.785 and 892.508 m/z correspond to monomer CaN B 
[M+21H]
21+
 and dimer CaN B [2M−2H+43H]
43+
, respectively. The area under peak (AUP) for 
each EIC at each condition was measured. At each condition the area under peak was converted 
to the percentage value, %AUPmomomer=[AUPmomomer/(AUPmomomer+ AUPdimer)] × 100.   
   condition 
Area under peak 
monomer (913.785 m/z) dimer (892.508 m/z) 
CN- DTT 78.3 21.6 
CN+15 min DTT 89.9 10.0 
CN+40 min DTT 92.4 7.5 




Figure 2.2. Activity assay of calcineurin in the absence and presence of 5 mM DTT. The assay 
performed using para-nitrophenyl phosphate (pNPP) in the assay buffer (50 mM Tris pH 7.5, 100 
mM NaCl, 6 mM MgCl2, 0.5 mM DTT, 0-200 mM pNPP, 0.5 mM CaCl2). The activity of CaN 
without DTT and CaN preincubated in 5 mM DTT for 40 min was assayed. The absorbance of 
nitrophenyl at 405 nm was then measured. The vertical axis is the absorbance and the horizontal 
axis is the length of the activity assay.  
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2.2.4 Hydrogen exchange mass spectrometry 
2.2.4.1 Calcineurin peptide identification 
 CaN peptic peptides were assigned using a combination of a time-of-flight mass 
spectrometer (Agilent 6220) and MS/MS enabled in a linear ion trap (Thermo LTQ-XL). In the 
first step, CaN sample (20 pmol) was loaded onto an HPLC system (1200 series) combined with 
a TOF mass spectrometer. The protein samples were digested online at 200 uL/min with mobile 
phase A using an immobilized pepsin column
(32, 33)
 (self-packed in a 2.1 mm × 100 mm column). 
The resulting peptides were captured and desalted on a C12 trap column over 4 min. The 
peptides were then separated using the following gradient: 5% B (0 min), 15% B (1 min), 45% B 
(9 min), 60% B (10 min), 95% B (11 min), 95% B (13 min), and 5% B (14 min) at 50 µL/min B. 
The peptides were identified on the basis of accurate mass (10 ppm mass tolerance) 
measurements using 4-GHz high-resolution mode of the TOF mass spectrometer. The peptides 
that could not be unambiguously assigned on the basis of accurate mass were assigned in a 
separate MS/MS experiments. The CaN peptic peptides were first prepared by offline digestion 
using an immobilized pepsin column at 200 µL/min at 4 °C using a syringe pump. The peptides 
were then collected and flash frozen with liquid nitrogen. Identity confirmation experiments on 
the basis of the collision-induced dissociation fragmentation were performed on a linear ion trap 
mass spectrometer combined HPLC (Shimadzu, Columbia, MD). The peptides were separated by 
HPLC on a C18 column (ZORBAX SB300-C18, 2.1 × 100 mm, Agilent) with a 110 min 0-60% 
B gradient (A: 99% H2O, 1% ACN, 0.1% formic acid; B: 99% CAN, 1% H2O, 0.1% formic acid; 
200 µL/min flow rate). Mass spectra were analyzed using the Proteome Discover 1.3 software 
(Thermo Scientific). Only MS/MS spectra with XCorr score of ≥2 were used to validate peptide 
assignments. A list of all assigned peptides from both set of experiments was made for the 
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hydrogen exchange analysis. A peptic peptide map, shown in Figure 2.3, covering 95% of each 
of the chain of CaN, CaN A and CaN B, was constructed from a total of 134 peptides that were 




Figure 2.3. Peptic peptide map of the (a) calcineurin A chain and (b) calcineurin B chain. The 
coverage map composed of 134 peptides covering 95% of each of the CaN A and CaN B 
primary sequence. These peptides were reproducibly obtained by pepsin digestion of CaN. The 





2.2.4.2 Calcineurin (RD-AID-CT)-calmodulin binding ratio 
 To determine the calcineurin (RD-AID-CT):calmodulin binding ratio, we performed HX 
using three different molar ratios of CaM 1:1, 1:2, and 1:3 and RD-AID-CT without CaM. The 
samples (12 µM RD-AID-CT (control) or in mixture with CaM at 12, 24, 36 µM) were prepared 
in H2O buffer (20 mM HEPES, 100 mM NaCl, 10 mM CaCl2, pH 7.5) and incubated at 4 °C for 
1 h before deuterium labeling. We used an H/DX PAL (LEAP Technologies, Carrboro, NC) 
robot system for sample labeling and quenching. We used one labeling time point (12 s) to 
monitor the protection from exchange according to different binding ratios. 3 µL of the samples 
were diluted 19-fold with D2O buffer (20 mM HEPES, 100 mM NaCl, 10 mM CaCl2, pD 7.5) 
and quenched with 1% formic acid by 1:1 dilution at 1 °C. For fully deuterated control, the RD-
AID-CT sample was incubated in D2O buffer for 24 hours before quenching the sample. 90 µL 
of the quenched solution was injected into the sample loop of a refrigerated compartment which 
includes an immobilized pepsin column, a peptide desalting trap (Porshell 120 EC-C18, 2.1 × 5 
mm, 2.7 µm particles, Agilent Technologies), and a C18 (Zorbax 300SB-C18, 1.8 µm particles, 
2.1 × 50 mm, Agilent Technologies) column. The compartment was held at 1 °C for this 
experiment. All LC-MS analysis of the samples were carried out on a quadrupole time-of-flight 
mass spectrometer (Agilent 6530, Santa Clara, CA, USA) combined with a multipump LC 
system (Agilent 1260). 
2.2.4.3 Calcineurin-calmodulin hydrogen exchange 
 We used an H/DX PAL (LEAP Technologies) robot system for sample handling for HX 
experiments. Calcineurin (CaN) (12 µM) containing 5 mM DTT was incubated with calmodulin 
(CaM) (12 µM) or an equal volume of H2O buffer (20 mM HEPES, 100 mM NaCl, 10 mM 
CaCl2, pH 7.5) for 40 minutes at 4 °C. The samples were then transferred to the robotic system 
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for labeling. 3 µL of the samples were diluted 19-fold with D2O buffer (20 mM HEPES, 100 mM 
NaCl, 10 mM CaCl2, pD 7.5) for between 13 s and 24 h at 25 °C. For a non-deuterated control, 
the samples were prepared similarly and diluted with H2O buffer instead of D2O buffer. The 
samples were quenched to a pH of 2.6 by addition of 1% formic acid at 1:1 dilution ratio. After 
quenching, the samples were loaded into the sample loop of the refrigerated compartment. To 
obtain more efficient pepsin digestion, the HPLC lines were extended to set the immobilized 
pepsin column outside the compartment in order to digest proteins at room temperature 
(23±1°C). The desalting trap and the reversed phase column remained inside the compartment 
where the temperature was maintained at 1 °C. After injection, the samples were digested online 
at 200 µL/min with 0.1% formic acid. The resulting peptides were captured and desalted on a 
reversed-phase trap (1 mm × 10 mm self-packed with Jupiter Proteo C12 media obtained from 
Phenomenex) over 5 min. The peptides were eluted from the trap and separated using a C18 
column (Zorbax 300SB-C18, 1 mm × 50 mm, 3.5 µm particles, Agilent Technologies). For 
gradient elution the mobile phases were 0.1% formic acid (A) and 90% ACN:10% water:0.1% 
formic acid (B). The gradient was as follows: 5% B (0 min), 15% B (1 min), 45% B (9 min), 
60% B (10 min), 95% B (11 min), 95% B (13 min), and 5% B (14 min) at 50 µL/min B. The LC-
MS analysis was carried out on a time-of-flight mass spectrometer (Agilent 6220) combined with 
a HPLC (Agilent 1200). The mass spectra were collected in positive ESI mode with a capillary 
voltage of 4000 V, fragmentor of 150 V, and temperature of 325 °C. 
2.2.4.4 Data Analysis 
 Mass spectra of the CaN peptides were analyzed using Agilent MassHunter Qualitative 
Analysis software (version B.06.00, Agilent). HDExaminer (version 1.0, Sierra Analytics, 
Modesto, CA) was used for initial deuterium calculation and data analysis. We processed three 
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replicate sets of HX data of CaN A and CaN B in the presence and absence of CaM to determine 
standard deviation values in the HX analysis. We used an R script, written in house, for 
deuterium uptake data averaging and plotting for a total of 134 peptides for CaN A and B. The 
standard deviation (SD) at each labeling time point and for each state of CaN was determined. 
We followed a method described by Houde et al. to determine statistical values for replicate 
differential HX data.
(35)
 A histogram of the statistical analysis of the data is shown in Figure 2.4. 
A statistical analysis of our triplicate measurements established that the 98
th
 percentile of the 
standard deviations (SD98%) was ±0.4 Da. For differential HX measurements, i.e., ∑Δm = 
∑mCaN+CaM − ∑mCaN, the 98% confidence limit was then propagated to account for all the time 
points together (9 time points for each state multiplied by 2) and the overall value, √18 ×  SD98%
22 , 
was 1.7 Da. Thus, if the summed deuterium difference is greater than 1.7 Da, this difference can 
be considered statistically significant at the 98% confidence level. All significant differences in 




Figure 2.4. Reproducibility of hydrogen exchange mass spectrometry data represented by the 
distribution of standard deviations for the mass differences across all time points and states of the 
calcineurin peptides from the triplicate experiments (N = 2222). The 98
th
 percentile for standard 
deviations was 0.4 Da.  
 
2.3 Results 
2.3.1 Stoichiometry of CaM:CaN RD-AID-CT is 1:1 
 Hydrogen exchange (HX) mass spectrometry was conducted to determine the 
stoichiometry of CaM:CaN complex. The complex has very tight binding with a Kd value in the 
picomolar range.
(24, 36, 37)
 In order to determine the binding ratio in solution, we monitored 
protection from exchange by CaN RD-AID-CT in the absence (control) and presence of CaM at 
three different binding ratios (CaN RD-AID-CT: CaM): 1:1, 1:2, and 1:3. We used one time 
point (12 s) to monitor the changes in HX for each peptide at each condition. The peptide 
deuterium content at each condition was converted to deuteration percentage to obtain an HX-
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MS heat map grouped by representative peptides from various regions of RD-AID-CT (see 
Figure 2.5). The deuterium uptake data were corrected for back exchange using a fully 
deuterated control.  When regulatory domain was in the free state, we observed full deuteration 
in the CaM binding site for the peptide A 382-406 at 12 s. The deuteration percentage decreased 
to 45% when regulatory domain bound to CaM at a 1:1 ratio for the peptide at the same time 
point. This result indicates that this region becomes significantly protected when CaM binds. We 
observed the same percentage of deuteration in the presence of CaM at two or three-fold molar 
ratios. The data indicate that CaM binds the calmodulin-binding domain of regulatory domain at 
a 1:1 binding ratio. In addition, we monitored the differences in deuteration percentages in the 
other regions of regulatory domain. We found that there are no differences in the exchange in the 
presence of CaM at different binding ratios. All the data indicate that the binding ratio of 
CaM:CaN RD-AID-CT is 1:1. These results are consistent with our previous measurements of 
HX in the RD-AID-CT construct carried out at 1:2.
(21)
 Thus, subsequent experiments with full-






Figure 2.5. Deuterium percentage heat map for the isolated calcineurin RD in the absence and 
presence of a one-fold, two-fold, and three-fold molar excess of calmodulin at 12 s labeling time 
point. The graph constructed from non-overlapping peptides representative from different 
regions of RD to monitor the changes in deuteration. The domain organization of the isolated RD 
is shown at top for reference. The representative peptide identity is shown at the end of each bar. 
The deuteration percentage in the presence calmodulin is compared to the deuteration percentage 
of free RD state (control).   
 
2.3.2 Effects of CaM binding to full length CaN 
 Hydrogen exchange mass spectrometry (HX-MS) was used to assess the effects of CaM 
binding on full length CaN conformation. Two sets of HX experiments on full-length CaN in the 
absence and presence of CaM at 1:1 binding ratio were run (see Materials and Methods section). 
The protein samples were incubated in deuterium-containing solutions for various time points 
followed by quenching the hydrogen-deuterium exchange reaction and then passed through a 
pepsin column. The deuterium content in the resulting peptides was measured by mass 
spectrometry (see Materials and Methods section). Data from representative peptides from 
various region of CaN A and B chains are shown in Figure 2.6. The deuterium uptake curves for 
all peptides of CaN in the absence and presence of CaM are presented in Figure 2.S2. The shapes 
of deuterium uptake profiles can provide information about flexibility in different regions of 
CaN. The differences in the rates of exchange between two states of the proteins can provide 
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information about CaN conformational change when CaM binds. We observed differences in the 
deuterium uptake between two states of CaN in several peptides from various regions of CaN. 
One other way to present the effects of CaM binding on CaN is differential deuterium uptake. 
The differential deuterium value of each peptide at each HX time point (13 s, 20 s, 40 s, 3 min, 
12 min, 48 min, 2 h, 8 h, 24 h) was calculated by deducting the deuterium value of free CaN 
from that of bound CaN, as shown in Figure 2.7 for both chains. The peptide number on the X-
axis is ordered from N-terminal to C-terminal region of CaN. The Y-axis is the summed 
difference for all HX time points for each peptides, ∑Δm = ∑mCaN+CaM − ∑mCaN. A positive value 
for ∑Δm indicates that the CaM binding caused faster exchange which means there is a decrease 
in protection (more flexible), while a negative value indicates slower exchange which means 
there is an increase in protection (less flexible). To set the criteria for determining statistically 
significant differences between two protein states, the 98% confidence interval (± 1.7 Da) was 
determined and plotted as dotted lines in the differential deuterium uptake (Figure 2.7) (see 
Materials and Methods section for the method of determination). The local differences are 
mapped onto the crystal structure of CaN as shown in Figure 2.8. The CaM-induced increases in 
local protection are colored in yellow, decreases in protection in green, and no changes in gray. 




Figure 2.6. Deuterium uptake curves for six representative peptides from different regions of 
calcineurin A and B chains. The peptide identity, charge state, peptide number (pn) 
corresponding to pn in Figure 2.7a for A chain and 2.7b for B chain, and amino acid sequence 
are provided on each plot. The open squares represent uptake by the free calcineurin (CaN) state 
and the black filled diamonds represent uptake by CaN bound to calmodulin state. The error bars 
denote standard deviation from triplicate measurements. The horizontal axis in each plot is the 
exchange time in seconds plotted on logarithmic scale and the upper limit of the vertical axis is 





Figure 2.7. Mass difference plots of calcineurin (CaN) (a) A chain and (b) B chain in the 
presence of calmodulin compared with the absence of calmodulin as measured by HX-MS. 
Deuterium uptake differences for the two states of CaN were calculated for all exchange time 
points and summed for all labeling time points, ∑Δm = ∑mCaN+CaM − ∑mCaN . The summed 
differences are plotted on the vertical axes. The horizontal axes denote the peptides numbered 
from the N-to-C termini of the CaN A and CaN B. The dashed line at ±1.7 Da indicates the 98% 
confidence limit for significant mass differences after propagating the standard deviation to 
account for all the time points together. The positive and negative bars represent peptides that 




Figure 2.8. Effects of calmodulin on calcineurin as measured by hydrogen exchange mass 
spectrometry displayed on the modified crystal structure of CaN (PDB 1AUI).
(16)
 The changes in 
protection are colored as shown in legend and are derived from the differential exchange data 
shown in Figure 2.7.  
 
2.3.2.1 CaM binds to CaN at the regulatory domain 
 To evaluate the local conformational impact by CaM binding, we compared the rate of 
HX of the free CaN and bound CaN states of the calmodulin-binding domain region. The 
deuterium uptake curves for all the peptides are presented in Figure 2.S2. Representative 
deuterium uptake data by a peptide from calmodulin-binding domain is shown in Figure 2.6 (A 
391-406). All the peptides located in the calmodulin-binding domain region exchange very 
rapidly in the absence of CaM and the exchanges were complete within fastest time point (13s), 
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indicating that the calmodulin-binding domain is unstructured in the absence of CaM. In 
contrast, when CaM binds the calmodulin-binding domain, the patterns of exchange by the 
peptides in this region become quite different. The rate of exchange becomes significantly slower 
after CaM binding and the peptides become strongly protected even after 24 h of exposure to D-
2O. We observed the largest increase in protection in the calmodulin-binding domain (see Figure 
2.7). The strongest protection was –53 Da. The overlapping peptides covering the calmodulin-
binding domain region are A 378-406, A 382-406, A 391-406, and A 407-413 (corresponding to 
peptide numbers 77-80 in Figure 2.7a, also see Figure 2.S2). In addition, CaM binding caused 
one other peptide in the regulatory domain (A 455-470 corresponding to peptide 91 in Figure 
2.7a), which is distant from the calmodulin-binding domain region, to exchange slightly slower 
than the free form of CaN. These are the only two regions in the regulatory domain where 
changes in protection from exchange when CaM binds full length CaN were observed. 
 Unlike our previous work with CaM binding to the isolated RD-AID-CT,
(21)
 in full length 
CaN, CaM binding did not cause statistically significant changes in protection from exchange in 
the peptides in the region adjacent to the C-terminal side of the calmodulin-binding domain, 
residues 414 to 450 (corresponding to peptide numbers 81-90 in Figure 2.7a).  
2.3.2.2 Allosteric effects of CaM binding 
 In addition to the calmodulin-binding domain conformational change, calmodulin binding 
led to allosteric changes in CaN in locations distant from the binding site. Calmodulin binding 
caused several regions in the catalytic domain of CaN to exchange differently. These peptides 
are located near CaN’s active site. The HX kinetics of one of the segments located in this region 
(A 303-311) is shown in Figure 2.6, while data for the other peptides are shown in Figure 2.S2. 
The peptides covering the area near the CaN’s active site are A 160-176, A 303-311, A 303-312, 
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and A 303-314 (corresponding to peptide numbers 34, 63-65 in Figure 2.7a). The deuteration 
percentages of these peptides in both states of CaN were very low (15-30%) even after 24 h of 
exposure to D2O. Although these peptides are located on the surface of the catalytic domain, 
proximity to the surface of the protein does not necessarily produce high deuteration.
(38)
 The 
peptides located in the area near CaN’s active site region exchange slightly more rapidly in the 
presence of CaM, indicating that this region become less protected after calmodulin binding. The 
strongest decrease in protection in the catalytic domain was 2.1 Da. There were no statistically 
significant differences in the other peptides located in the catalytic domain including CaN B-
binding domain.  
2.3.2.3 Effects of CaM binding on CaN B chain 
 Another region that undergoes altered hydrogen exchange after CaM binding is in the 
CaN B chain (CaN B). The HX kinetics of one of the segments located in this region (B 153-
169) is shown in Figure 2.6, while data for the other peptides are shown in Figure 2.S2. We 
observed a significant increase in protection in peptide segments located in the C-terminal region 
of CaN B in the presence of calmodulin. The peptides covering the C-terminal region of CaN B 
are B 153-169, B 155-169, B 160-169, and B 161-169 (corresponding to peptide numbers 36-39 
in Figure 2.7b). The strongest protection for this region was −5.4 Da. For the other regions of 
CaN B, there were no statistically significant changes in the deuterium uptake data.  
2.3.2.4 CaM binding does not induce any changes in hydrogen exchange by the 
autoinhibitory domain      
 The peptides covering the AID region showed no changes in protection from exchange. 
These peptides are A 457-470, A 471-496, and A 472-496 (corresponding to peptide number 92-
94 in Figure 2.7a, also see Figure 2.S2). Representative deuterium uptake data by the peptide A 
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471-496 are shown in Figure 2.6. The hydrogen exchange by the peptides located in this region 
reached a plateau within fastest time point (13 s) in the absence of CaM. When calmodulin 
bound the calmodulin-binding domain, no changes in the deuterium uptake by the peptides were 
observed. 
2.4 Discussion 
To explain the mechanism of CaN activation by CaM binding, we need to have a good 
understanding of the detailed structure and dynamics of CaN in solution in both states: free and 
bound to CaM. The previous models of CaN activation were either based on studies using 
truncated region of CaN or based on crystallographic studies using full-length CaN. In such 
cases, the models of activation may not reliably represent how full-length CaN undergoes 
conformational change in solution. In addition, some of the models were only based on low 
resolution biochemical and biophysical techniques. Our main goal in this study was to 
understand the mechanism of CaN activation in solution at higher resolution. For this purpose, 
we have used HX mass spectrometry to determine the CaN conformation at high calcium 
concentrations in the absence and presence of its binding partner, CaM, using full-length CaN. 
Here, we discuss the most widely accepted model of CaN activation, what we observed with the 
HX mass spectrometry data, and finally propose a new model of activation. 
 There is limited information about CaN conformation at no or low calcium 
concentrations and absence of CaM. The available information about CaN in this state is based 
on limited proteolysis and some other biochemical studies. Based on limited proteolysis of CaN 
in the absence of calcium, the calmodulin-binding domain and AID of the CaN regulatory 
domain are protected against proteolytic attack, indicating these two regions of the regulatory 
domain may remain packed against the CaN catalytic domain.
(5)
 At high calcium concentration, 
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calcium binds to the low-affinity sites on CaN B, resulting in dissociation of the calmodulin-
binding domain from the CaN catalytic domain and the protein becomes partially active.
(15)
 The 
crystal structure of full-length CaN at high calcium concentration in the absence of calmodulin 
was first resolved by Kissinger et al. (see Figure 2.1, PDB: 1AUI).
(16)
 In this structure, the 
electron density for the major part of regulatory domain including calmodulin-binding domain 
and C-terminal side of the regulatory domain is missing, indicating the disordered nature of these 
domains in the presence of excess of calcium in the absence of CaM. Fourier transform infrared 
spectroscopy and HX mass spectrometry data for the isolated RD-AID-CT construct also showed 
that the regulatory domain is disordered in the absence of CaM.
(21, 39)
 A crystal structure of full-
length CaN at high calcium concentration in the presence of calmodulin is not available to 
describe the conformational transition from a partially active form to the fully active form. Based 
on biochemical and biophysical techniques using both full-length CaN and truncated CaN 
constructs,
(21, 40, 41)
 a model for CaN activation in the presence of calcium/calmodulin has been 
proposed and described as follows. At high calcium concentration, CaM binds four calcium ions 
and then subsequently binds to the calmodulin-binding domain of CaN. This binding causes a 
significant ordering in the calmodulin-binding domain and a weak ordering in a 38-residue 
region C-terminal to the calmodulin-binding domain of the regulatory domain. It has previously 
proposed that this ordering may cause displacement of the AID from the CaN active site leading 
to fully activated CaN.
(21)
 Several techniques including HX, circular dichroism, and fluorescence 
anisotropy for the study have been used. The previous work supported the accepted mechanism 
of CaN activation. Since the previous HX data was mostly based on data obtained from the 
isolated RD-AID-CT, we wanted to extend the HX work using full-length CaN. The goal in the 
present work was to understand the conformational transition from partially active to fully active. 
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For calmodulin-binding domain, we observe that calmodulin-binding domain becomes 
fully deuterated within fastest labeling time point, indicating that calmodulin-binding domain 
might be unstructured in the absence of CaM. It seems that this region is very flexible and lacks 
detectable stable secondary structure in the absence of CaM (see Figure 2.6 and 2.7a). The 
crystal structure of CaN is missing this region, indicating that this region is unstructured in the 
absence of CaM.
(16)
 But when CaM binds CaN regulatory domain, the calmodulin-binding 
domain becomes strongly protected from HX, indicating that this region becomes structured (see 
Figure 2.6, 2.7a, 2.8, and 2.S1). This structuring is expected to be an α-helix in the calmodulin-
binding domain.
(21, 42)
 This kind of structuring happens with many other proteins contain 
calmodulin-binding domain.
(20, 43, 44)
 Similarly, using Fourier transform infrared spectroscopy to 
determine the secondary structure of CaN in the presence and absence of CaM, Zhao et al. 
demonstrated that the regulatory domain of CaN undergoes a large-scale folding.
(26)
 Thus, these 
HX results are consistent with the accepted models regarding calmodulin-binding domain. 
 The HX data for the adjacent region to the calmodulin-binding domain, however, look 
different than what was previously observed for this region. Previous HX data on the isolated 
regulatory domain fragment of CaN demonstrated that there is weak protection in the region 
adjacent to the C-terminal region of calmodulin-binding domain.
(21)
 In full-length CaN, however, 
we did not observe any significant protection from exchange in the weakly-protected region on 
the C-terminal side of the calmodulin-binding domain after CaM binding (see Figure 2.6, 2.7a, 
and 2.8). The rate of exchange by the peptides in this region was very rapid in both the presence 
and absence of CaM (see Figure 2.6 and 2.S2). Our data from full-length CaN do not agree with 
the previously published HX data obtained from the isolated regulatory domain fragment of CaN 
in this region. Based on the full-length CaN HX data in the presence and absence of CaM, we 
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conclude that the flexibility of the region immediately next to the C-terminal site of the 
calmodulin-binding domain remains unaffected by CaM binding. Our data suggest that this 
region does not engage with CaM as previously proposed. The reason could be because CaM 
may either prefer interacting with another region of CaN B which did not exist in the isolated 
regulatory domain experiment or because CaM may prefer interacting with the region N-terminal 
to the AID, or both.     
 Full-length CaN HX data also demonstrated that another region in the regulatory domain 
immediately N-terminal to the AID becomes weakly protected after CaM binding (A 455-470) 
(see Figure 2.6 and peptide 91 in Figure 2.7a), but such protection was not observed in the 
isolated regulatory domain fragment of CaN.
(21)
 Other work also suggests that the region 
adjacent to the N-terminal region of AID has a role in regulating the CaN activation. Perrino et 
al. have shown that there is 38-residue region adjacent to the N-terminal of AID that has a role in 
the activation of CaN.
(41)
 Using enzyme activity assays, they found that the deletion of the AID, 
but not the regulatory domain, caused CaN to become partially active. Full activation of CaN 
was only observed when the 38-residue region and the AID were deleted.
(22, 41)
 Based on the 
activity assays data and our HX data, the region adjacent to the N-terminal region of AID might 
have a role in CaN activation and there might be an interaction between this region and CaM, but 
the interaction is likely not very stable as indicated by only a weak protection from exchange 
(see Figure 2.7a and 2.8). Based on different HX results obtained for isolated regulatory domain 
fragment versus full-length CaN, our data lead us to conclude that HX studies on truncated 
region of CaN may not accurately represent some aspects of the conformational changes that 
CaM binding induces in the whole protein. 
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   The HX data from full-length CaN demonstrate that the CaM binding leads to allosteric 
effects in the area near active site in the catalytic domain. In contrast to the other regions of CaN, 
this region is the only region of CaN to become more flexible after CaM binding to CaN. A 
slight decrease in protection from exchange was observed in the peptides located in the regions 
near the active site (see Figure 2.6, 2.7a, and 2.8). The allosteric effects in this region appear to 
have a role in regulating the CaN activations because this region may be directly affected when 
CaN become fully active and ease the binding of CaN to its substrate. Previous studies showed 
that there is a relation between the active site of enzymes and their flexibility.
(45-47)
 It is been 
suggested that the enzyme active sites need to be flexible to ease the conformational change 
during activation or inactivation. Although there is a change in the HX by the peptides located 
near the active site of the catalytic domain, the deuteration percentages of these peptides were 
very low (15-30%). Since these peptides are located on the surface of the catalytic domain, they 
might be expected to exchange rapidly. However in contrast to this assumption, the proximity to 
the surface of the protein does not necessarily cause rapid exchange.
(38, 48)
 These peptides might 
have slowly exchanging amide hydrogens that are hydrogen bonded to hydrogens of the same 
helix or hydrogen bonded to a defined water molecules that also hydrogen bond to main chain 
carbonyls. 
 Another region that undergoes altered hydrogen exchange is CaN B. We found that the 
peptides located in the C-terminal region of CaN B become significantly protected after CaM 
binding. Other regions of CaN B remain unaffected by CaM binding (see Figure 2.6, 2.7b, 2.8, 
and 2.S1). Previous kinetic analysis demonstrated that the presence of CaN B was required for 
CaN activation.
(22)
 Based on our data, one possible interpretation is that the protection in the C-
terminal region of CaN B is a result of an allosteric effect of CaM binding. One other 
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interpretation is that there is an interaction between CaN B and calmodulin. We favor the 
interpretation of the binding between CaN B and calmodulin because CaN B may regulate the 
CaN activation by anchoring the calmodulin to the calmodulin-binding domain. From the folded 
conformer of calmodulin bound to the calmodulin-binding domain peptide (PDB: 4Q5U),
(24)
 we 
learn that calmodulin is about the same size as CaN B chain. Examination of the crystal structure 
of CaN free form (see Figure 2.1b), suggests that there is about the right amount of space for 
CaM to fit into the space between the catalytic domain and CaN B to keep the CaN in the active 
form. One example of similar conformation is the conformation of CaN bound to the drug-
protein complex cyclosporine A-cyclophilin (PDB: 1MF8).
(14)
 In the crystal structure, the drug-
protein complex also fills the space between the catalytic domain and CaN B. Although the 
CaN/drug/protein complex is an inhibitory interaction in which some details are different than 
CaN:CaM binding, they might have a similar conformation. Therefore, we suggest that the 
interaction between the C-terminal region of CaN B and CaM and on the other hand, the 
interaction between the region immediately N-terminal to the AID and CaM may favor to form 
the space-occupied conformation of the CaN:CaM complex and cooperatively activate CaN. 
 The most interesting aspect of the full-length CaN HX data is what we found for the AID. 
We do not see changes in deuterium uptake by the peptides located in the AID region after CaM 
binding (see Figure 2.6, 2.7a, 2.8, and 2.S1), indicating that there is no structural change in the 
AID. The peptides in the AID were already about 50% deuterated at the fastest measured 
exchange time and remained at the same percentage even after 24 hours labeling. Based on our 
data, there are two possible interpretations to explain rapid, but low deuteration for the peptides 
in the AID region. One possible interpretation is that some residues of the AID are highly 
protected. The other possible interpretation is that the AID region undergoes extensive back-
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exchange. To investigate which interpretation might be correct, we compared back exchange 
percentages of the AID peptides from full length CaN experiment with the same peptides from 
the RD-AID-CT construct isolated from full length CaN experiment. Since there is no active site 
in the isolated form of RD-AID-CT, there is nothing for the AID to bind to. Therefore, the back 
exchange percentage comparison would tell us whether the low deuteration of the AID peptides 
in full length of CaN is either due to extensive back-exchange or structural protection. We 
observed that the back exchange for the AID peptides in the isolated form of RD-AID-CT is also 
about 50-55%. The back exchange percentage is similar to the back exchange percentage 
observed for the AID peptides in the full-length CaN experiment. Thus, we prefer the second 
interpretation: that the AID peptides undergo extensive back-exchange under quench conditions. 
Based on our HX data for the full-length CaN, the AID is either unstructured and has no 
interaction with the catalytic domain or is unstructured and has interaction with the catalytic 
domain only through side chains. The HX experiment is not able to distinguish between these 
two possible states of the AID. Thus, based on our data, we can state that the AID is 
unstructured, not folded into the active site of CaN, and CaM binding does not change the HX of 
AID. This observation does not agree with the widely accepted model of CaN activation. Several 
contradictory results were reported about the AID and its role in the CaN activation. For 
example, Wang et al. reported that the activity of truncated form of CaN, which contains the 
calmodulin-binding domain (residue 1- 420), is higher than the native enzyme in the presence of 
calcium/CaM.
(40)
 In another activity assay study, however, a similar activities were reported for 
the same truncation of CaN and the native full length CaN.
(39)
 In a separate study, Ye et al. 
reported a crystal structure of CaN covalently linked to CaM which exhibits full CaM-activated 
activity (PDB: 4IL1).
(25)
 Although CaM was covalently linked to CaN, CaM does not appear in 
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the crystal structure. In the study, no conformational change of the AID was observed, indicating 
that the AID was not released from the active site. It has also been suggested that the AID does 
not only include the region (468-490) as previously thought, but might also include other regions 
of the regulatory domain. Based on these results, the idea of reclassification of the AID has been 
suggested.
(25)
 Based on our HX data from full-length CaN, the AID is unstructured and could be 
bound to the catalytic domain segments through side-chain contacts. If the AID associated with 
the catalytic domain only through side chain interactions, we would not know that these had been 
lost when CaM binds. The interaction would be invisible by HX for the AID. However, 
decreased protection in the catalytic domain segments could be explained by release or 
reorientation of an unstructured AID that only makes side-chain contacts.  
 The crystal structure of the β CaN isoform was recently solved to characterize the 
mechanism of CaN activation.
(49)
 Based on biochemical studies, CaM does not remove the AID 
from the active site. The study also reports a structure of full length β CaN isoform which reveal 
an autoinhibitory segment (AIS) within the regulatory domain of CaN A. In the absence of CaM, 
this segment appears to be packed into a hydrophobic intersubunit (CaN A and B) groove. In 
contrast, in the crystal structure of α CaN isoform (see Figure 2.1b), there is no evidence of the 
so-called AIS present in the structure. It has been suggested that the AIS is untraceable in α CaN 
due to AIS’s high flexibility.
(49)
 Based on our HX data, we conclude that the AIS (A 407-414) is 
very flexible and unstructured in the absence of CaM as this region becomes fully deuterated 
within fastest labeling time point. It is possible that the AIS exists in two conformations. If this 
were the case, we might see EX1 kinetics, which produces bimodal isotopic distributions in the 
mass spectra,
(50, 51)
 in the AIS. However, we do not see evidence of EX1 kinetics in the AIS that 
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would support the existence of two conformations of AIS in α and β CaN might represent 
snapshots of the ensemble conformations (see Figure 2.S3). 
 In summary, based on HX results obtained from full-length αCaN presented here in this 
study, we propose a model for the mechanism of CaN activation as shown in Figure 2.9. Since 
we ran our HX experiment in the presence of high calcium concentration, our model of 
activation is only focused on the structural changes in the presence or absence of CaM. The low- 
and high-affinity sites on CaN B and CaM are already occupied with calcium to stimulate the 
basal activity of CaN in the absence of CaM. In the absence of CaM, the AID is unstructured and 
bound to the active site through side chains and the other part of regulatory domain including 
calmodulin-binding domain and CT are largely unstructured. In the presence of CaM, a series of 
conformational changes, both near and distant from the active site, are responsible for regulation 
of CaN activity. The CaM binding causes calmodulin-binding domain to form an α-helix in this 
region. The C-terminal region of CaN B and the region immediately N-terminal to the AID 
interact with CaM to anchor CaM to the binding site. The CaN:CaM binding causes the area near 
the active site to become slightly more flexible. One possible explanation for the slight increase 
in flexibility in this region might be because of reorientation of the AID. Our model of CaN 
activation is based on data obtained from a technique that can provide molecular details with 
high spatial resolution at the peptide-level to probe conformational changes in solution. Our 
model challenges the currently available models of CaN activation. To investigate the complex 
multistep regulatory mechanism of CaN activation and have a complete story of the activation, 




Figure 2.9. Proposed model of calcineurin activation after calmodulin binding based on full-
length calcineurin data. The proposed model based on data obtained by HX-MS for two states of 
CaN: CaN at high calcium concentration in the absence of CaM shown in the left panel of the 
figure and CaN at high calcium concentration in the presence of CaM shown in the right panel of 
the figure. The open dots represent calcium ions bound to CaN B and calmodulin. The purple 
and light blue dots in the catalytic domain represent zinc and iron ions, respectively.  
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Figure 2.S1. Deconvoluted spectra and mass spectra (shown in the insets) of calcineurin B in (a) 
the absence of DTT and (b) in the presence of DTT after incubation for 40 min at 4 °C. In the 
inset figure (a), the m/z values of 913.78 and 892.50 correspond to monomer CaN B [M+21H]
21+
 
and dimer CaN B [2M−2H+43H]
43+
, respectively. The CaN B monomer theoretical mass was 
19168.7 Da and the dimer mass was 38335.4 Da (2×M – 2H). The intensity of the dimer 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































    
  
Figure 2.S2. Hydrogen exchange by peptides from CaN as measured by HX-MS comparing free 
CaN and bound CaN to the calmodulin. The identity of the peptides is shown at the top of each 
uptake plot. The blue lines represent uptake by the peptides of free CaN state and the red lines 
represent uptake by the peptides of bound CaN state. 























Figure 2.S3. Mass spectra of a representative peptide located in the AID region of calcineurin A 
in the free state at different labeling time points. The identity, charge state, and sequence are 
provided at the top of the spectra. The spectra confirm that there is no evidence of EX1 kinetics 





Exploring the best reference state to quantify the degree of 
structure in disordered proteins using millisecond HX-MS  
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3.1 Introduction  
Intrinsically disordered proteins (IDPs) have regions that are highly flexible and lack 
stable secondary or tertiary structure.
(1-6)
 Recently, there has been growing interest in IDPs due to 
their important role in many biological processes and functions. The biological functions include 
transcriptional regulation, cellular signaling, post-translational modification, and cellular 
recognition.
(7-9)
 IDPs are associated principally with functions that require protein-protein 
interactions such as in cellular signaling.
(7)
 Although many studies have shown that IDPs 
participate in functional interactions, less is known about the structural details of the interactions.  
One of the key advantages of IDPs is their highly dynamic conformations that mediate 
protein-protein interaction through the phenomenon of coupled folding and binding.
(10-12)
 In this 
type of interaction, folding of a disordered protein occurs upon engagement with its binding 
partner. Two modes of binding have been proposed. Conformational selection is one of the 
modes of binding proposed in IDP interactions. According to this mode of binding, transiently 
folded states, which exist within many conformational states of disordered proteins, can be 
selected by the binding partner to allow binding. The other mode of binding is the induced 
folding mode. In this case, the conformation flexibility of a single disordered protein can ease the 
interaction with its binding partner. This interaction leads to folding the disordered protein.
(13, 14)
 
More detailed information is required to understand the complexity of mechanisms of protein-
protein interaction involving disordered proteins. Also, localized information about the presence 
or absence of transiently folded conformers of IDPs in the free state can be very important to 
provide support for one proposed mode of binding over the other.  
Many techniques have been employed to provide information about structure of IDPs.
(14-
19)
 NMR and amide hydrogen exchange (HX) mass spectrometry are among the techniques that 
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can measure the degree of protein structure with high spatial resolution in IDPs. The rate of 
amide HX is highly dependent on hydrogen bonding and solvent accessibility which is related to 
the conformational flexibility of the protein backbone.
(20, 21)
 Highly flexible regions will 
exchange more rapidly, while rigid regions exchange more slowly.
(22)
 Millisecond HX can be a 
very useful technique to characterize IDPs because most of the exchange occurs on this timescale 
at room temperature and near neutral pH.
(23-26)
 Protection in HX experiments, which is a measure 
of the slowing of exchange caused by structure, can reveal information about protein structures. 
The degree of protection can be directly related to the degree of structure if the observed rate of 
HX is compared to the rate of HX by an unprotected reference state. The unprotected reference 
state should represent the fastest possible exchange in order to quantify the degree of protection. 
A higher degree of structure causes the more protection. Without an unprotected reference state, 
it is impossible to estimate such protection because the unprotected reference state is an essential 
part in measuring protection. Generally, the chemical exchange, calculated using an empirical 
formula based on unstructured model peptides
(27)
, is used as an unprotected reference state. 
Using chemical exchange as a reference state here is the key in measuring the protection. Any 
inaccuracy in the unprotected reference state would underestimate or overestimate the degree of 




 have found that the calculated chemical 
exchange does not seem to be accurate enough to be used as an unprotected reference state in 
weakly protected IDPs. In some cases, the chemical exchange calculations were slower than HX 
by unstructured peptides.  
In this work, we explore different approaches to prepare an unprotected reference state 
for quantifying the degree of structure in IDPs. We employed a quench-flow device, built in-
house,
(30)
 for HX labeling on the millisecond timescale. The interaction domains of the activator 
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for thyroid and retinoid receptors (ACTR) and the CREB binding protein (CBP) were used as 
model IDPs to explore the best approach to produce an unprotected reference state for 
millisecond HX. ACTR is a near-random coil IDP that has some residual helicity
(11, 23, 31, 32)
 
while CBP is a molten globular IDP that transiently becomes unstructured as revealed by NMR 
and HX-MS.
(23, 24, 32, 33)
 We have tested three different methods that can be used to prepare an 
unprotected reference state. These methods are chemical exchange calculations, addition of 
denaturing agents, and millisecond HX labeling of peptic peptides obtained from the IDP. In 
addition, two unstructured model peptides have been used as internal standards to see how 
changes in solution could alter chemical exchange. We have found that the peptic reference 
peptide can be used as an accurate unprotected reference state for determining the degree of the 
structure.      
3.2 Materials and methods 
3.2.1 Protein expression and purification 
ACTR
1023-1093
 (UniProt NCOA3_HUMAN) and CBP
2059-2117
 (UniProt CBP_MOUSE) 
domains were co-expressed from a pET22B co-expression vector
(11)
 in Escherichia coli BL21 
(DE3) and separately purified.
(23)
 A single colony was selected to inoculate 25 mL of LB 
medium after overnight incubation at 37 °C on ampicillin/LB agar plates. The cells were 
incubated overnight at 37 °C in a rotary shaker at 225 rpm. 10 ml of the starter culture was then 
transferred to 500 mL of LB medium containing ampicillin. The cultures were induced with 1 
mM IPTG after the OD600 had reached 1.0 and incubated for an additional 4 h at 37°C in a rotary 
shaker at 225 rpm. The cells were then pelleted at 5000g for 10 min at 4°C and then stored at –80 
°C. Ten mL of lysis buffer [20 mM Tris, 1 mM EDTA, 1g/L lysozyme, and 5 units benzoase 
nuclease (pH 7.5)] with (250 µL/g pellet) protease inhibitor cocktail [23 mM AEBSF, 2 mM 
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bestatin, 0.3 mM pepstatin A2, and 0.3 mM E-64] were used to resuspend the cell pellet by 
gentle agitation at room temperature for 10 min. The lysate were centrifuged at 15000g for 10 
min at 4°C to remove cell debris.  A fast protein liquid chromatography FPLC system 
(AKTAPrime Plus, GE Healthcare, Piscataway, NJ) was used to purify proteins at 4 °C using 
214 nm detection. Ion exchange was used to isolate ACTR and CBP as they have different 
predicted pI values of 4.2 and 11.1, respectively. For ACTR purification, the lysis buffer was 
first exchanged for anion exchange buffer (50 mM piperazine pH 9.0) using a desalting column 
(HiPrep 26/10 Desalting, GE Healthcare). Protein fractions containing ACTR were pooled after 
identification by SDS-PAGE and passed through an anion exchange column (HiTrap Q XL, GE 
Healthcare) in 50 mM piperazine (pH 9.0) using a 0 to 1 M NaCl gradient over 70 min at a rate 1 
mL/min. After that, fractions containing ACTR were pooled and passed through a gel filtration 
column (HiPrep 16/60 Sephacryl S-100 HR, GE Healthcare) in 10 mM sodium phosphate and 50 
mM NaCl buffer pH 6.9. For CBP purification, the lysis buffer was first exchanged for cation 
exchange buffer (50 mM boric acid pH 9.0) containing 3 mM dithiothreitol, to avoid methionine 
oxidation, using a desalting column (HiPrep 26/10 Desalting, GE Healthcare). Protein fractions 
containing CBP were pooled after identification by SDS-PAGE and passed through a cation 
exchange column (HiTrap SP FF, GE Healthcare) in 50 mM boric acid and 3 mM DTT buffer 
(pH 9.0) using a 0 to 1 M NaCl gradient over 70 min at a rate 1 mL/min. After that, fractions 
containing CBP were pooled and passed through a desalting column in 10 mM sodium phosphate 
and 50 mM NaCl buffer pH 6.9. Protein stocks were split into aliquots and frozen and stored at –
80°C. An aliquot was then taken and dialyzed against 20 mM sodium citrate and 100 mM NaCl 
buffer (pH 6.5) for 2 hours followed by overnight dialysis at 4 °C using mini dialysis device 
(Slide-A-Lyzer 2000 MWCO, Thermo Scientific). The ACTR and CBP concentration were then 
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determined to be 18.8 µM and 17.2 µM, respectively, using a BCA assay
(34)
 standardized with 
BSA (Thermo Fisher Scientific). 
3.2.2 Preparation of peptic reference peptides 
Before starting the preparation of peptic peptides, ACTR was concentrated by freezing 3 
mL of stock with liquid nitrogen followed by lyophilizing using LABCONCO Freezone (model 
7670521, Kansas City, MO, USA). The ACTR was reconstituted in 1 mL of ultrapure water. 
Then the sample was dialyzed against citrate buffer (pH 6.5) two times for two hours each 
followed by overnight dialysis at 4 °C using mini dialysis device (Slide-A-Lyzer 2000 MWCO, 
Thermo Scientific). The concentration of ACTR stock was 45.2 µM. ACTR peptic peptides were 
prepared by diluting 50 µL of (45.2 µM) ACTR to 2.2 mL with 0.1% formic acid and 150 µL of 
stock CBP (17.2 µM) was diluted to 2.4 mL with 0.1% formic acid. The samples were passed 
through an immobilized pepsin column, described in the following section, using a syringe pump 
at a flow rate 50 µL/min at room temperature. The digested sample was dried using a 
LABCONO CentriVap Concentrator (model 780016) combined with Freezone for 1 hour at 40 
°C. The dried samples were reconstituted in 50 µL of citrate buffer (pH 6.5), frozen, and stored 
at –80 °C.  
3.2.3 Hydrogen exchange labeling 
Millisecond hydrogen exchange (HX) was conducted using a home-built quench-flow 
device as described previously
(24)
 (see section 1.3.3.3) with some improvements in syringe types 
and fittings. ChemSeal syringes with 1/4-28 thread tip (Hamilton, Reno, NV) were used instead 
of syringes with luer lock tip to prevent leaks at high flow rate because this type of syringe has a 
pressure limit of 14 bar. All three syringes were connected to three lines of fused silica 
capillaries with adapter assembly (P-627 female 10-32 coned to female 1/4-28 thread 
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configuration, IDEX, Oak Harbor, WA). NanoTight tubing sleeves (F-242) and fittings (F-300) 
(IDEX, Oak Harbor, WA) for the assembly were used to connect the silica capillaries and the 
assembly. All other parts of the quench-flow system remained the same as described previously 
in more detail.
(24)
 ACTR and CBP were labeled with separate sets of experiments using the 
quench-flow device. The ACTR (8 µM) and CBP (8 µM) proteins were compared with their 
reference peptides ACTR (3 µM) and CBP (3 µM), respectively. All four samples were spiked 
with two internal standard peptides FKPGI (GenScript, Piscataway, NJ) and YPI (AnaSpec, 
Fremont, CA) used here as rapidly and slowly exchanging peptides, respectively. The samples, 
in H2O buffer (20 mM sodium citrate, 100 mM NaCl, pH 6.5), were labeled with a 5-fold excess 
of D2O buffer (20 mM sodium citrate, 100 mM NaCl, pD 6.5). According to the applied flow 
rates, the labeling time ranged between 42 and 3500 milliseconds. The labeled samples were then 
quenched at a 5:6 volume ratio with quench buffer (200 mM sodium phosphate, pH 2.3). Then 
the quenched samples were immediately flash-frozen with liquid nitrogen and kept at –80°C 
until analysis. Fully deuterated controls were labeled manually with a 5-fold excess of D2O 
buffer for 18 hours and then quenched at a 5:6 volume ratio with the quenching buffer. 
Undeuterated controls, the samples were diluted 5-fold with H2O buffer instead of D2O buffer 
and followed the steps for quenching and flash-freezing the samples. All HX labeling was 
carried out at room temperature (23±1°C) in triplicate for each labeling time point. 
To measure chemical exchange in different buffers, a slowly exchanging model peptide 
(YPI) was labeled for between 20 to 4000 sec (standard timescale) using an H/D-X PAL robot 
(LEAP Technologies, Carrboro, NC). Three deuterium labeling buffers, (20 mM sodium citrate, 
100 mM NaCl, pD 6.5, control), (3 M deuterated guanidine hydrochloride with 97%D, 20 mM 
sodium citrate, 100 mM NaCl, pD 6.5) and (6 M Urea-d6 (99.9%), 20 mM sodium citrate, 100 
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mM NaCl, pD 6.5), were used to label the sample at 5:1 (v:v) ratio. The exchange was quenched 
by 5:6 dilution in a quench buffer (200 mM sodium phosphate, pH 2.3). The quenched samples 
were analyzed immediately. Fully deuterated guanidine hydrochloride was initially prepared by 
dissolving 1.5 g of guanidine hydrochloride in 15 ml D2O (99.9%D). The solution was left 
overnight for complete deuteration at room temperate. Then the solution was flash-frozen 
followed by an overnight freeze-drying cycle. A second round of dissolution/lyophilization of 
guanidine in D2O was repeated to obtain more deuteration. The degree of deuteration of 
guanidine hydrochloride, as measured by 
1
H NMR on a Bruker DRX-500 spectrometer, was 
97%D (see Figure 3.S1).   
3.2.4 Chemical exchange calculations 
The rate of chemical exchange by amide hydrogens was calculated using a sum of 
exponentials for each amide in a peptide using equation (1).
(27)
  





             (1) 
Where n and 𝑘ch
(𝑖)
represent the number of residues and the rate constant of chemical exchange
(27)
 
for residue i of a peptide, respectively.  ∆𝑚 is the extent of deuteration at D2O exposure time t. 
As it shown in the equation (1), the value of i begins with 3. The reason is that the back-
exchange is quite fast for the first two residues of the peptide during proteolysis and LC steps.
(27, 
35)
 The rate constant for proline residues was zero because there is no amide hydrogen. To 
calculate chemical exchange, we used an Excel spreadsheet which calculates chemical HX based 
on empirically derived formulas
(27, 35)
 adapted from a spreadsheet provided by the Englander Lab 
(available online http://hx2.med.upenn.edu/).  To compare the HX kinetics in experimental and 
theoretical states, we normalized the chemical exchange, ∆𝑚ch(𝑡), to the ratio between the 
114 
 
measured mass increase, ∆𝑚QF , of the latest measured time point for each peptide, tmax and the 
calculated mass increase for chemical exchange, ∆𝑚ch, at the same tmax.  
                ∆𝑚ch(𝑡)(normalized) = ∆𝑚ch(𝑡) ×
∆𝑚QF(𝑡max)
∆𝑚ch(𝑡max)
      (2)  
 To measure differences in the chemical exchange rate caused by different solution 
conditions, we measured hydrogen exchange by an unstructured peptide (YPI) on the seconds-to-
hours timescale (standard timescale). The HX data were collected in 20 mM sodium citrate, 100 
mM NaCl, pD 6.5 buffer without denaturants (control) and in the presence of 3 M guanidine or 6 
M urea. Since YPI has only one amide that undergoes measurable exchange, the hydrogen 
exchange data for YPI peptide were fit to the equation (3) using non-linear least squares 
regression (SigmaPlot 12.5, Systat Software Inc., San Jose, CA) as shown below: 
                   ∆𝑚 (𝑡) = 𝑦 + 𝑎 (1 − e−𝑘 𝑡 )   (3) 
Where k represents the rate constant for exchange and a represents the deuterium recovery. The 
best fits were achieved by incorporating y in the equation and y represents deuteration at t equal 
to zero. The best fits were also achieved for each condition within 10-20 iterations. 
3.2.5 LC-MS analysis 
ACTR peptic peptides were assigned using MS data from a time-of-flight mass 
spectrometer (Agilent 6220) and MS/MS data from  a linear ion trap (Thermo LTQ-XL), as 
described previously.
(36)
 CBP peptides were assigned using a quadrupole time-of-flight mass 
spectrometer (Agilent 6530). Several different gradients were used to separate and identify CBP 
peptides. MS/MS spectra of CBP peptides were assigned using Mass Hunter Qualitative 
Analysis (version B.06.00). Each MS/MS spectrum was examined to validate the assignment of 
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the CBP peptides and take out all potential in-source fragmented peptides that have same C-
terminus with same retention time.  
All LC-MS analysis of labeled sample was carried out on a time-of-flight mass 
spectrometer (Agilent 6220, Santa Clara, CA, USA) combined with HPLC (Agilent 1200 series). 
Individual frozen samples were thawed by hand for 3 minutes immediately before injection into 
a refrigerated column compartment built in-house.
(30)
 The temperature of the compartment was 
maintained at 0°C. The LC mobile phases were 0.1% formic acid in water (A) and 90% 
acetonitrile/10% water with both containing 0.1% formic acid (B). After injection, the protein 
samples were digested online through an immobilized pepsin column
(37, 38)
 (self-packed in a 2.1 
mm × 100 mm column) at 200 µL/min with A. The peptides were trapped and desalted over 4 
min on a reversed phase C12 trap (Jupiter 4 µm Proteo 90 Å, C12 (Phenomenex) packed by 
Optimize Technologies (Apple Valley, Minnesota) in a 1.5 × 5 mm OPTI-LYNX II cartridges). 
The resulting peptides were then separated on a C18 column (ZORBAX 300SB, 3.5 µm, 1 × 50 
mm) using a gradient (5-60% B over 6 min for ACTR peptides, 5-45% over 6 min for CBP 
peptides) at 50 µL/min. All mass spectra were measured in positive ESI mode with a capillary 
voltage of 4000 V, drying gas flow 10 L/min, fragmentor 150 V, and temperature of 325°C. 
HDExaminer (version 2.0, Sierra Analytics, Modesto, CA) was used for initial deuterium 
calculation and data analysis. After that, the time required to reach 50% deuteration (t50%) for 
each peptide in both states of proteins was measured.
(36)
 For the peptide-level t50% calculation, the 
deuterium uptake values were exported from HDExaminer to a spreadsheet and normalized to 
100% using the totally deuterated controls. Then, the t50% values for each state were calculated 
using linear interpolation between the two points that spanned 50% exchange. The t50% ratio 
(hereafter referred to as protection ratio) was then determined from the t50% value of the protein 
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segment measured under native condition divided by the t50% value of the unprotected reference 
state. Since there were many overlapping peptides for ACTR but not for CBP, we calculated the 
residue-resolved protection ratio. The ACTR residue-resolved t50% ratios were determined as 
explained in previous work.
(36)
 We used the equation 4 to calculate the value, as follows: 
                 𝑡50%,𝑗 =
∑ (𝐸𝑖,𝑗.𝑡50%,𝑖.𝑤𝑖)𝑖
∑ 𝑤𝑖𝑖
    (4) 
First, we mapped the protection ratio on each residue, j, of a given peptide, i, of the 
ACTR protein. Then, a separate exchangeability matrix Ei,j was made for each residue in each 
peptide. The value of Ei,j is one if the residue reports on the exchange, while the value is zero if 
the residue does not report on the exchange. All proline residues, which do not have amide 
hydrogens, and first two residues in a given peptide, which undergo rapid back-exchange under 
quench conditions
(27, 35)
, have Ei,j equal to zero. Equation 4 also takes the peptide length into 
consideration by using a weighting function, wi, equal to(∑ 𝐸𝑖,𝑗𝑖 )
−2. The weighting function is 
used to give more weight to shorter peptides with fewer exchangeable amide hydrogen rather 
than long peptides because shorter peptides give better spatial resolution. The residue-resolved 
t50% ratio was then calculated from the given equation values.  
3.3 Results 
Hydrogen exchange (HX) can provide structural details about intrinsically disordered 
proteins (IDPs) with high spatial resolution. Since the rate of hydrogen exchange is highly 
dependent on the conformational flexibility of proteins, most of HX occurs on the millisecond 
timescale at neutral pH and room temperature for IDPs. With a quench-flow apparatus, we can 
perform HX at timescales ranging from 42 – 3500 msec. We used ACTR and CBP as model 
systems for conformational analysis of IDPs. ACTR is a mostly unstructured protein that 
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transiently occupies a folded state as described by NMR and HX-MS.
(11, 23, 24, 31, 32)
 In contrast, 
CBP is a mostly helical molten globule that transiently occupies an unfolded state as described 
by NMR and HX-MS.
(23, 39-41)
 In order to determine the degree of structure in IDPs by HX, an 
accurate unprotected reference state is required to avoid any misleading information about the 
structure. The unprotected reference state here represents HX by the protein in its fully 
unprotected state giving the fastest possible rate of HX. Slower exchange by a segment 
compared to its unprotected reference state indicates the region is structured.   
In this chapter, we explore different approaches to prepare an unprotected reference state 
that can be used for mapping the degree of structure in IDPs. These approaches are chemical 
exchange calculation, addition of denaturing agents, and HX labeling of peptic peptides. In an 
ideal case, the rate of exchange by the reference will be the same as the exchange by an 
unstructured peptide. For chemical exchange, the unprotected reference state is based on 
theoretical calculations. We used free peptides to test whether the measured rate of exchange 
matched the calculated rate. For addition of denaturing agents, we tested with free peptides to see 
whether unstructured peptides have the same rate of HX in denaturants. Finally, for peptic 
reference peptides, we compared HX in the unstructured regions of the proteins with HX by the 
same regions as isolated peptides, and then compare measured protection to known secondary 
structural elements. 
3.3.1 Calculated chemical exchange as an unprotected reference state  
To evaluate the accuracy of calculated chemical exchange as an unprotected reference 
state, we compared HX data from unstructured peptides with calculated exchange. If chemical 
exchange calculations are accurate then we would expect that the measured rate of HX would be 
the same as calculated exchange. Two representative deuterium uptake plots of peptic reference 
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peptides from ACTR (residues 1023-1032) and CBP (residues 2059-2068) are shown in Figure 
3.1. The white filled points denote the peptic reference peptide deuterium uptake from the 
proteins and the black filled triangles denote the calculated deuterium uptake for the 
corresponding peptides. As shown in Figure 3.1a and 3.1b, the reference peptides from ACTR 
and CBP exhibit faster exchange than predicted by calculation. There is a discrepancy between 
measured and predicted HX and this discrepancy is the case for all the reference peptides from 
ACTR and CBP (see Figure 3.S2). To determine if the difference in the exchange is not only 
related to ACTR and CBP peptides, we used two model peptides, YPI and FKPGI. Recently, an 
internal standard peptide (PPPI) was used in an HX experiment to compensate for any possible 
differences in chemical exchange rates caused by different solution conditions.
(29)
 Here, we have 
used two unstructured model peptides, FKPGI and YPI, to compare the HX predicted by 
calculation with the HX by the peptides measured under native condition. Our model peptides 
were selected by selecting some characteristics of unstructured peptides. These two peptides are 
short which reduces the likelihood of folding and they contain proline which breaks a possible 
helix due to its side chain steric interferences. The residues of the two peptides also have poor 
helix-forming propensity.
(42)
 All these criteria make the YPI and FKPGI useful models of 
unstructured polypeptides Because the first two amide hydrogens undergo a rapid back-exchange 
under quench conditions and proline does not have an amide hydrogen, YPI has only one slow 
exchangeable residue, isoleucine. YPI exchanges at standard timescale and can be described by 
first-order kinetics.
(43)
 FKPGI has two amides that undergo measurable exchange, isoleucine and 
glycine, with slow and fast rates of exchange, respectively.
(27)
 We compared the HX data of the 
model peptide (FKPGI) with the calculated exchange on the millisecond timescale. As shown in 
Figure 3.1c, again HX by the model peptide is faster than calculated exchange. To confirm that 
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the differences in the exchange are not related to our quench-flow system, we also used 
conventional labeling for YPI deuteration under native conditions at the standard labeling 
timescale and compared it with chemical exchange calculation. The results were the same as for 
FKPGI in millisecond timescale. The exchange by YPI was faster than exchange predicted by 
chemical exchange calculation as shown in Figure 3.1d. The rate of exchange differences of the 
chemical exchange with already unstructured peptides may yield unreliable calculation for the 
degree of structure of the IDPs. Therefore, the chemical exchange calculation may not be 
sufficiently accurate for an unprotected reference state for weakly protected and unprotected 




Figure 3.1. Deuterium uptake curves for representative peptides from (a) ACTR, (b) CBP, and (c 
and d) two unstructured model peptides. The open circles represent uptake by the peptic 
reference peptides and the black filled triangles represent the chemical exchange calculation 
normalized to match the latest measured time point of each respective curve. The error bars 
denote standard deviation from triplicate measurements. The horizontal axis in each plot is the 
exchange time in seconds and the vertical axis is the number of exchangeable amides by each 
peptide. The horizontal dashed line represents the maximum deuterium uptake measured after 
exchange for 12 h. All the data were acquired with the quench-flow system between 42 – 3500 
milliseconds except for YPI (d) where the data were acquired at standard timescales. See text for 
additional details.  
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3.3.2 Protein HX in the presence of denaturants as an unprotected reference state  
Another possibility is to prepare an unprotected reference state by incubating the proteins 
in denaturants before millisecond HX labeling. Measuring HX in the presence of denaturants, 
unlike chemical exchange calculation, is based on experimental measurement. The denaturing 
agents may promote unfolding of proteins both directly by disrupting hydrogen bonding and 
indirectly by altering water structure and dynamics mechanism
(44)
 to make even disordered 
proteins completely unstructured. Denaturing conditions remove protection thereby causing the 
rate of exchange to become as fast as possible. For this purpose, we tested two common 
denaturing agents, urea and guanidine. We carried out the HX experiments with labeling time 
points ranging from 20 sec to 4000 sec. We compared the HX by the slowly-exchanging 
unstructured peptide, YPI, in the absence of denaturants (control) with the presence of 3 M 
guanidine or 6 M urea in citrate buffer (pD 6.5). YPI is unstructured, and expected to have no 
protection when HX data in the absence of denaturant is compared with the presence of 
denaturants. Thus, we would expect the rate of exchange by YPI in the absence and presence of 
denaturants would be the same if this method is a good unprotected reference state. The HX data 
of the model peptide in these conditions are shown in Figure 3.2. The black filled points denote 
deuterium uptake by the peptide under a non-denatured condition in citrate buffer (pH/pD 6.5), 
and the white filled triangles and squares denote deuterium uptake in the presence of guanidine 
(3 M) and urea (6 M), respectively. Since YPI has only one exchangeable residue and is well-
described by single exponential function, each curve was fitted as described by equation 3 in the 
Materials and Methods section. The curve fitting parameters are listed in Table 3.1. From the 
curve fitting, rate constants for each state were calculated. The rate constant for YPI in the 
absence of denaturant, the presence of 3 M guanidine, and the presence of 6 M urea conditions 
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were 0.0058, 0.0085, and 0.0031 s
-1
, respectively (Table 3.1 and Figure 3.2). Urea and guanidine 
have significant and opposing effects on hydrogen exchange. In the case of adding guanidine to 
the buffers, the model peptide exchanged more quickly than in the absence of denaturant. The 
rate of HX in guanidine-added conditions speeds up by a factor of 1.46. While in the case of 
adding urea to the buffers, there is an opposite effect. The model peptide exchanged more slowly 
in the urea-added conditions and the rate of HX in the presence of 6 M urea slows down by a 
factor of 1.87. Because YPI peptide is designed not to have any conformational protection, the 
fast exchange in guanidine and slow exchange in urea is a reflection of the differences in the 
solution conditions that alter the chemical exchange process. These differences may not affect 
the actual protection coming from the degree of structure of proteins. Therefore, the addition of 
denaturants to the proteins may not work as an unprotected reference state for IDPs because it 
would underestimate the degree of structure in the case of urea or overestimate the degree of 




Figure 3.2. Hydrogen exchange for the unstructured model peptide (YPI) at three conditions: 
HX measured with no denaturant in citrate buffer at pD 6.5 (control) (filled points), in the 
presence of 6 M urea (open squares), and in the presence of 3 M guanidine (open triangles). The 
HX data were fit to equation 3 (see text for details) to obtain the rate constants for hydrogen 








Table 3.1. Fitting parameters and rate constants for YPI at three different conditions. HX 
measured with no denaturant in citrate buffer at pD 6.5 (control), in the presence of 6 M urea, 
and in the presence of 3 M guanidine. The fitting parameters were obtained using equation 3 (see 
text for details). 
Condition y (Da) a (Da) k  (s
-1
) 
No denaturants 0.15 0.64 0.0058 
6 M urea 0.07 0.72 0.0031 
3 M guanidine 0.11 0.67 0.0085 
 
 
3.3.3 Peptic peptides as an unprotected reference state  
Another way to prepare an unprotected reference state might be simply by labeling the 
peptides obtained by pepsin digestion of the proteins. We expect that the peptic reference 
peptides are unstructured because they are derived from already disordered proteins which have 
low hydrophobic and high polar and charged content of amino acid residues. This characteristic 
would make it difficult for the peptides to adopt secondary and tertiary structure. In this 
approach, the rate of chemical exchange is estimated based on an experimental determination of 
HX in an unprotected reference state. The hydrogen exchange labeling would occur using the 
same buffer system with the same composition which is an advantage point to this approach. The 
N-terminal segments of ACTR are completely unstructured under native conditions as revealed 
by NMR data.
(31)
 Thus, if the HX by the peptic reference and the HX by the protein in the N-
terminal region are the same, there would be good evidence that the peptide is an accurate 
unstructured reference. Unstructured internal standard peptides were added to confirm that the 
two states had consistent labeling. We carried out offline ACTR and CBP digestion to obtain the 
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peptides, as described in the Materials and Methods section. We carried out millisecond HX 
labeling on peptic peptides obtained from ACTR and CBP and compared the rates of HX with 
the rates of HX obtained from intact ACTR and CBP. Figure 3.3 shows representative deuterium 
uptake curves comparing HX by reference peptides with HX by two segments of ACTR and two 
segments of CBP measured under native conditions. The white filled squares denote the 
deuterium uptake by the proteins in unprotected reference state and the black filled diamonds 
denote the deuterium uptake by the proteins measured under native conditions. A complete set of 
deuterium uptake curves for ACTR and CBP in both states are provided in Supporting 
Information Figure 3.S3 and Figure 3.S4, respectively. To quantify the difference in HX between 
the reference and measured states for each segment of the proteins, we used the protection ratio, 
the ratio of t50% of a peptide in the unprotected reference state to the t50% of the measured state, as 
described in Materials and Methods section. An unstructured peptide should have a ratio of 1 
because there is no protection meaning that the segment exchanges at the same rate as its 
reference peptide. If there is protection from exchange, then the protection ratio becomes greater 
than 1. A Table listing of all the peptides and their protection ratios is provided in Supporting 
Information (Table 3.S1). We have mapped all the protection ratios onto the primary sequence of 




Figure 3.3. Deuterium uptake curves for the distinct regions from ACTR and CBP. (a) and (b) 
are representative peptides from ACTR and (c) and (d) are representative peptides from CBP. 
The horizontal axis in each plot is the exchange time in seconds and the vertical axis is the 
number of exchangeable amides by each peptide. The white filled squares represent uptake by 
the peptic reference peptides and the black filled diamonds represent uptake by the protein 
measured under native conditions. The error bars denote standard deviation from triplicate 
measurements. The horizontal dashed line represents the maximum deuterium uptake measured 





Figure 3.4. Measurement of residual helicity in ACTR. Segment-averaged protection ratio for 
each peptic peptide of ACTR was mapped onto the primary sequence and secondary structure (a) 
that ACTR forms in complex with its binding partner, CBP. 
(31)
 The protection ratios were 
calculated as described in the text. The protection ratios are indicated by the blue color scale with 
lighter blue represents lower protection. Two peptides in the middle region of ACTR, colored in 
black, were excluded from the calculations because they did not reach 50% exchange. Residue-
averaged protection ratio obtained by averaging the peptide data (a) is shown in (b). The 
horizontal dashed line in (b) crossed the vertical axis at a value of 1 means there is no protection. 
Secondary chemical shift data obtained by NMR
(31)





Figure 3.5. Measurement of residual helicity in CBP. Segment-averaged protection ratio for 
each peptic peptide of CBP was mapped onto the primary sequence and secondary structure (a). 
The protection ratios were calculated as described in the text. The protection ratios are indicated 
by the blue color scale with lighter blue represents lower protection. Three peptides of CBP, 
colored in black, were excluded from the calculations because they did not reach 50% exchange. 
Secondary chemical shift data obtained by NMR
(39)
 is shown in (b). The plot was digitized using 
plot digitizer available online at http://arohatgi.info/WebPlotDigitizer/app/ 
 
For HX measured under native conditions, ACTR 1023-1035 segment exchange at the 
same rate as its peptide reference (see Figure 3.3a). This segment is located in the N-terminal 
region of ACTR which is an important region to validate the peptide reference state approach 
because NMR data show that this region is unstructured.
(31)
 In contrast, we observed a significant 
protection from the exchange by ACTR 1051-1057 segment measured under native condition, as 
indicated by exchanging slower than its peptide reference (see Figure 3.3b). For the N-terminal 
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and C-terminal segments of ACTR, we observed no or slight difference with protection ratio less 
than 1.1. These segments cover 1023-1044 of the N-terminal region and 1087-1093 of the C-
terminal of ACTR (see Figure 3.4a and Table 3.S1). The observed HX in these segments is 
consistent with the HX by their peptide references. However, in the middle regions of ACTR, 
several segments were significantly protected from HX. The segments cover 1038-1069 of the 
middle region of ACTR (see Figure 3.4a and Table 3.S1). Among these segments, there is only 
one segment with protection ratio as high as 11, which represents the highest degree of structure 
in ACTR. For ACTR, we could also calculate residue-averaged protection ratios because there 
were many overlapping peptides to calculate the protection for each residue. The residue-
averaged data (see Figure 3.4b) is presented in the Discussion section.   
For CBP, we observed substantial protection from exchange in CBP (2059-2068), located 
in the N-terminal region of the protein (see Figure 3.3c). This segment spans three residues of a 
region with the most intense value of NMR secondary chemical shift (see Figure 3.5b).
(39)
 CBP 
2102-2117 was also protected from the exchange as shown in Figure 3.3d, but the amount of 
protection is not as much in the N-terminal segment of CBP. Two segments (2066-2071 and 
2069-2072) in the N-terminal region, colored in black (Figure 3.5a), are excluded from 
protection ratio calculation because they did not reach 50% exchange. For segment (2102-2109), 
there was not enough data in the HX by the segment measured under native conditions. In 
general, there is protection from exchange along all the length of CBP. The amount of protection 
varies from region to region. For example, the protection ratio for CBP 2072-2088, 2084-2099, 
and 2089-2097 segments were as high as 11 (see Figure 3.5 and Table 3.S1). In the C-terminal 
region of CBP, there is only one segment (CBP 2110-2117) with protection ratio equal to 1. With 




To shed some light on the mechanism of coupled folding and binding by IDPs and their 
interaction partners, we need to have a good understanding of the detailed structure of IDPs in 
the unbound state. It would be very difficult to investigate such a complex mechanism without 
knowing the IDPs conformations that may have transiently-folded conformers under native 
conditions. Previous work showed that millisecond HX can provide vital information about IDPs 
and their interactions.
(23, 24, 26, 36, 45)
 It is essentially impossible to determine the degree of 
structure without having an accurate unprotected reference state. Our primary goal in this study 
was to develop a method that can accurately measure the degree of structure. For this purpose, 
we have tested several theoretical and experimental options to identify the best approach to 
generate an unprotected reference state for measuring the degree of structure in IDPs. 
In the first attempt to have an accurate unprotected reference state, we used chemical 
exchange calculation as an unprotected reference state. We observed that ACTR and CBP 
peptides exchange significantly faster than the calculated exchange. Two model peptides, FKPGI 
and YPI, also exchanged faster than the calculated chemical exchange (see Figure 3.1). It is 
unlikely that this effect is due to structural protection of ACTR and CBP segments in their 
unstructured regions because we observe the same effect when we compared peptic reference 
peptides of the proteins and also for FKPGI peptide with their calculated chemical exchange (see 
Figure 3.1 and 3.S2). It is also unlikely that this effect is due to our quench-flow system because 
we also observe the differences in YPI exchange on seconds to hours timescale using more 
precise robotic labeling (see Figure 3.1d). Most of the ACTR and CBP segments exchange more 
quickly than the calculated exchange have residues such as alanine, leucine, and arginine with 
the least helical propensity.
(42)
 The two model peptides also contain residues with very poor 
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helical propensity like proline, isoleucine, and lysine
(42)
 and are short peptides. Previously, Del 
Mar et al. reported that many segments across regions of α-synuclein, an intrinsically disordered 
protein, exchange at rates faster than the calculated chemical exchange rate.
(28)
 Based on what we 
found for the calculated exchange and what others previously observed
(28)
 the chemical exchange 
calculation is not accurate enough to measure protection in IDPs. The chemical exchange 
calculations are based on measured HX rates obtained using model dipeptides, oligopeptides, and 
polypeptides at the high ionic strength (0.5 M KCl).
(27)
 The calculation accounts for the inductive 
and steric effects of the neighboring side chains but longer range effects might also be present. 
So, in many cases, this calculation may not be reliable for different solution conditions, for 
example, low ionic strength or high concentrations of additives such as guanidine and urea in 
buffers. These factors may lead to larger deviations from ideal solution behavior. Some other 
factors need to be accounted for in the HX. These include the labeling ratio as we have 1:5 
sample-to-labeling buffers in this experiment and also other electrostatic field effects of side 
chains of disordered proteins. All these factors may have led to the acceleration of the chemical 
exchange for the ACTR, CBP, and the model peptides. Thus, if the protection ratio were 
determined using chemical exchange calculation, it would underestimate the degree of 
protection. The data would become misleading about the structure of IDPs. In contrast, the error 
in the degree of protection for well-folded proteins might become unimportant because the 
difference between the measured rate of exchange and the rate of chemical exchange is often 
many orders of magnitude. Therefore, a better choice is to find a way to measure chemical 
exchange experimentally and directly for IDPs.     
We tested an experimental method to completely unfold the proteins using urea and 
guanidine to produce an unprotected reference state. However, we observed a significant 
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decrease in HX rate of the model peptide (YPI) in the presence of urea and an opposite effect in 
the presence of guanidine (see Figure 3.2). We found that the rate of exchange in 6 M urea was 
1.87 slower than the control condition and the exchange percentage decreased from 48% down to 
28% in the presence of urea when compared at t50% for control YPI. In contrast, the rate of 
exchange in 3 M guanidine was 1.47 faster than the control condition and the exchange 
percentage increased from 48% up to 63% in the presence of guanidine. Urea can form hydrogen 
bonds with NH group of peptides thus leading to protection from HX due to changes in the 
solution conditions that alter the rate of chemical exchange.
(46)
 Guanidine has some impact on 
the acid-catalyzed peptide hydrogen exchange.
(46)
 A theoretical correction of the data might be 
able to compensate for the differences raised by the difference in buffer compositions. For 
example, Zhang et al. used an internal standard peptide (PPPI) in different guanidine 
concentrations for this purpose.
(29)
 However, the data correction may not be reliable enough to 
map degree of structure across all the regions of IDPs because they are only weakly protected at 
most. 
We found that peptic reference peptide for millisecond HX is the best method to quantify 
the degree of protection. Before validating this approach, we employed two model peptides as 
internal standards to confirm that the experiments have consistent labeling. The results show that 
the rates of HX are the same in both states confirming good labeling control (see Figure 3.S5). 
We observed similar rates of HX with protection ratio close to 1 for the N-terminal segments of 
ACTR (1023-1034, and 1023-1036) which showed no residual helicity by NMR secondary 
chemical shift
(31)
 (see Figures 3.4c and 3.S3). Our data demonstrate that the peptic reference 
peptide method can work as a good unprotected reference state. Because any difference in the 
composition of the buffer may result in the differences in the exchange rate, one of the major 
133 
 
advantages of using peptic reference peptide as an unprotected reference state is that there is no 
need to change the composition of the buffers. The other advantage is that no synthetic peptide 
standard is needed.   
There are extensive NMR data characterizing residual structure in ACTR in both the 
isolated form and in complex with CBP. 
(11, 31, 33, 39, 47)
 On the basis of the NMR data, ACTR has 
the characteristics of an unstructured random coil that transiently folds in the regions that form 
helices in the complex with CBP. Because ACTR has both unstructured and transiently 
structured regions, it is a good model to determine the validity of an unprotected reference state. 
In general, we found good agreement between the millisecond HX and NMR secondary chemical 
shifts for measuring residual structure in ACTR. The highest percentage of residual helicity is 
located in helix 1 when the NMR data of ACTR is measured relative to reference shifts measured 
in 6 M urea (see Figure 3.4c).
(31)
 Although urea might have effects on chemical HX, NMR 
chemical shifts only depend on the protein structure. Our millisecond HX data are in good 
agreement with NMR data. 
 In the N-terminal region of ACTR, we observed the lowest segment-averaged protection 
ratios. To calculate protection ratio at near single-residue resolution, a weighted residue-by-
residue average of the segment-averaged protection ratio was used. We mapped the residue-
averaged protection ratio on the amino acid sequence of ACTR. We observed a very good 
agreement for the N-terminal region of ACTR between the residue-averaged protection ratio and 
NMR data (see Figures 3.4b and 3.4c). The same agreement was observed for the C-terminal 
region of ACTR. Although the residue-averaged protection ratio showed the highest residual 
structure in helix 1 region and is in good agreement with NMR data (see Figures 3.4b and 3.4c), 
the t50% value is displaced more toward the N-terminal region. The reason for this displacement 
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is that the number of segments accounted for with the residue-averaged protection ratio 
calculation is low. There is only one segment that spans residues 1045-1051 leading to decreased 
spatial resolution in this region. In addition, two other segments, 1051-1054 and 1058-1061, 
were excluded from residue-averaged protection ratio calculation because they did not reach 
50% exchange (see Table 3.S1). These two peptides (RALL, HTLL) are short segments that end 




The apparent structure across most regions of CBP, as shown in our data (see Figure 
3.5a), is consistent with the NMR data. We only used segment-averaged protection ratio because 
the number of peptides for CBP was limited which makes the residue averaging calculation 
unreliable. Unlike ACTR, CBP has the characteristics of a molten globule that transiently 
becomes unstructured.
(23, 39-41)
 In general, we find a good correlation between the segment 
averaged protection ratio with NMR secondary chemical shift data.
(39)
 The C-terminal region of 
CBP was the least protected, with protection ratios ranging from 1 to 3 (see Figure 3.5a, and 
Table 3.S1). These data are in a good agreement with NMR data in the helix 3 region. However, 
we see some discrepancy in the N-terminal region because there are not enough segments to 
cover only unstructured the residues of CBP, 2059-2067 and 2079-2085. There are two other 
segments, 2066-2071 and 2069-2072, in this region that are excluded from the protection ratio 
calculation because they did not reach 50% exchange on this time scale. These segments, 
SALQDL and QDLL, also have leucine residues at the end of the segment which slow down the 
chemical exchange. 
Our approach for mapping the degree of IDPs structure relies on the use of peptic 
reference peptides as an unprotected reference state in the HX experiment. This approach can 
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offer a simple, easy to apply, and reliable empirical unprotected reference state. There is clearly 
no need to change buffer composition by adding a chemical denaturant to obtain an unprotected 
reference state. Data normalization due to altered buffer composition is not required making it 
less susceptible to HX miscalculations. We successfully mapped the degree of protection in two 
different model IDPs, ACTR and CBP. This approach can give a new insight into the analysis of 
transient structure in other IDPs. However, this approach may not work for all kinds of proteins 
because if a peptide can form structure even after protein digestion then it cannot act as an 
unprotected reference peptide. This could be a problem for globular proteins that have a much 
stronger tendency to fold. In such cases, peptic peptides in a low denaturant concentration might 
be a better choice. 
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Table 3.S1. ACTR and CBP peptic peptides t50% values at each state and their protection ratio.   
   t50% (s)  
protein residues sequence reference native t50% ratio 
ACTR 1023-1030 GTQNRPLL 0.31 0.19 0.63 
ACTR 1023-1032 GTQNRPLLRN 0.3 0.24 0.8 
ACTR 1023-1034 GTQNRPLLRNSL 0.19 0.21 1.09 
ACTR 1023-1035 GTQNRPLLRNSLD 0.39 0.41 1.06 
ACTR 1023-1036 GTQNRPLLRNSLDD 0.42 0.6 1.45 
ACTR 1031-1044 RNSLDDLVGPPSNL 1.32 1.4 1.06 
ACTR 1035-1044 DDLVGPPSNL 1.46 1.29 0.88 
ACTR 1037-1044 LVGPPSNL 0.32 0.27 0.85 
ACTR 1038-1044 VGPPSNL 0.17 0.45 2.7 
ACTR 1045-1054 EGQSDERALL 0.15 1.6 10.84 
ACTR 1051-1057 RALLDQL 1.96 2.66 1.36 
ACTR 1055-1061 DQLHTLL 0.21 0.65 3.05 
ACTR 1058-1064 HTLLSNT 0.36 0.4 1.11 
ACTR 1058-1068 HTLLSNTDATG 0.33 0.42 1.29 
ACTR 1058-1069 HTLLSNTDATGL 0.47 0.91 1.93 
ACTR 1058-1071 HTLLSNTDATGLEE 0.71 1.02 1.43 
ACTR 1062-1069 SNTDATGL 0.3 0.9 3.04 
ACTR 1062-1071 SNTDATGLEE 0.74 1.06 1.43 
ACTR 1070-1081 EEIDRALGIPEL 3.31 3.7 1.12 
ACTR 1072-1081 IDRALGIPEL 1.84 3.11 1.7 
ACTR 1082-1093 VNQGQALEPKQD 0.57 1.03 1.8 
ACTR 1087-1093 ALEPKQD 1.82 1.97 1.08 
CBP 2059-2068 PNRSISPSAL 0.18 1.86 10.08 
CBP 2072-2088 LRTLKSPSSPQQQQQVL 0.18 1.78 9.67 
CBP 2075-2088 LKSPSSPQQQQQVL 0.19 0.96 4.94 
CBP 2084-2099 QQQVLNILKSNPQLMA 0.19 1.61 8.51 
CBP 2089-2097 NILKSNPQL 0.28 3.14 11.32 
CBP 2092-2097 KSNPQL 1.08 1.83 1.69 
CBP 2092-2099 KSNPQLMA 0.51 1.82 3.57 
CBP 2098-2101 MAAF 1.63 2.58 1.58 
CBP 2100-2117 AFIKQRTAKYVANQPGMQ 0.38 0.59 1.53 
CBP 2101-2109 FIKQRTAKY 0.17 0.34 2.06 
CBP 2101-2117 FIKQRTAKYVANQPGMQ 0.19 0.47 2.42 
CBP 2102-2117 IKQRTAKYVANQPGMQ 0.19 0.37 1.9 







Figure 3.S1. Deuteration of guanidine. 
1
H NMR data for (a) guanidine hydrochloride (control) 
and (b) guanidine after complete deuteration in D2O (99.9 %) at room temperature with two 
rounds of dissolution/lyophilization as described in the text. The deuteration percentage was 
calculated after normalization the integration value of the solvent (DMSO) proton peak (2.5 
ppm) in both conditions to 1.0. The guanidine deuteration percentage (97 %D) was then 
calculated using the number of protons (peak 7.2 ppm) in deuterated guanidine and the number 





Figure 3.S2. Hydrogen exchange by peptides from ACTR and CBP. The blue lines represent 
uptake by the peptic reference peptides and the gray lines represent the chemical exchange 
calculation normalized to match the latest measured time point of each respective curve as 






Figure 3.S3. Hydrogen exchange by peptides from ACTR. The blue lines represent uptake by 
the peptic reference peptides and the red lines represent uptake by the protein measured under 






Figure 3.S4. Hydrogen exchange by peptides from CBP. The blue lines represent uptake by the 
peptic reference peptides and the orange lines represent uptake by the protein measured under 





Figure 3.S5. Deuterium uptake curves for two unstructured model peptides, (a) FKPGI and (b) 
YPI. The open triangles represent uptake by the peptide in reference states and the open circles 
represent uptake by the peptides measured under native conditions. The error bars denote 
standard deviation from triplicate measurements. The horizontal axis in each plot is the exchange 
time in seconds and the vertical axis is the number of exchangeable amides by each peptide. The 






Application of fast photochemical oxidation of proteins 


















 Intrinsically disordered proteins (IDPs) have regions that are highly flexible and lack 
stable secondary or tertiary structure.
(1-3)
 Although many studies have shown that IDPs 
participate in functional interactions, less is known about the structural details of the 
interactions.
(4, 5)
 Since IDPs are unfolded or partially unfolded and are very flexible, they have a 
high solvent accessible surface. These properties of IDPs represent a challenge for some 
biophysical techniques to analyze this class of proteins.       
Over the past two decades, mass spectrometry (MS) has become a powerful technique for 
biophysical characterization of proteins due to its high sensitivity and variety of choices for 
sample preparation and instrumentation.
(6-8)
 One of the mass spectrometry based techniques used 
for IDPs conformation and dynamic studies is hydrogen exchange mass spectrometry (HX-
MS).
(9-11)
 See Section 1.3.3 for details about HX-MS. Although HX-MS has shown promise in 
analysis of folded proteins and their complexes, the application of conventional HX is still 
limited in IDPs studies. The reason is because of highly flexible and rapidly fluctuating 
secondary and tertiary structure properties of IDPs which results in complete exchange prior to 
the first HX measurements. More sophisticated HX techniques are required in order to probe the 
structural change in IDPs. One of these techniques is by using millisecond HX
(10, 12)
 (see Section 
1.3.3.3 and Chapter 2 of this Dissertation). In general, HX-MS can provide an average picture of 
the protein conformational changes that are induced by mutation, aggregation, and ligand and 
partner protein binding.
(13-15)
 On the other hand, HX has some limitations. One of the limitations 
is the requirement of specialized LC-MS-based strategies to preserve the deuterium label of a 
protein.
(16)
 In HX experiments, it is required to minimize back-exchange (deuterium label for 





 In addition, HX-MS provides structural information based on 
amide backbone hydrogens but does not probe side chain residues. Finally, the spatial resolution 
in a typical HX-MS experiment is highly dependent on the proteolytic digestion step prior to MS 
analysis.
(16)
 HX-MS can provide localized structural information at a resolution of 5-10 amino 
acid residues. Therefore, there is a need for other techniques that lack the limitations mentioned 
above and have better resolution for analyzing IDPs.   
In this work, we evaluate the application of another MS-based protein footprinting 
technique to study the conformational change of an IDP upon binding to a partner IDP. The 
technique is fast photochemical oxidation of proteins (FPOP). The FPOP technique is based on 
covalent labeling of amino acid side chains of a protein with hydroxyl radicals generated by 
H2O2 photolysis into two hydroxyl radicals by an excimer laser (λ=248) that leads to oxidative 
modification of the surface accessible residues
(18, 19)
 (see Section 1.3.4.2 for more details). This 
technique is based on probing solvent accessibility of amino acid side chains by modifying the 
side chains, and such modification is irreversible and can be preserved throughout the subsequent 
steps: proteolysis and LC-MS/MS analysis.
(16, 18, 20)
 Single amino acid resolution can be achieved 
with the use of this technique. Although the hydroxyl radical reaction with side chains is non-
specific, the reactivity of labeling side chains is not equal. Table 4.1 lists rate constants of the 
reaction of different amino acid side chains with hydroxyl radicals.
(21)
 As shown in the table, 
hydroxyl radicals label side chains with different efficiencies. To explore the applicability of this 
technique for studying IDPs, we used ACTR and CBP. ACTR and CBP are useful models for 
conformational analysis of IDPs. On their own, CBP is a mostly helical molten globule while 
ACTR is unstructured.
(22-24)
 The proteins bind with high affinity to form a well-defined complex 
with three helices each.
(22, 23, 25)
 Our previous work showed that HX can provide important 
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information about IDPs, but only when labeling takes place on the millisecond-second 
timescale.
(12)
 Since protein folding is slower than microseconds, fast photochemical oxidation of 
proteins (FPOP) might reveal states of IDPs that are undetectable by HX. Here, we used FPOP 
technique to study ACTR and CBP in their free and bound forms. The data show that FPOP can 
provide valuable information to compare two states of IDPs. The data illustrate the usefulness 
and limitations of FPOP-MS analysis to characterize and localize regions of protein-protein 
interactions involving intrinsically disordered proteins. 







rate (M-1 s-1) pH 
Cys (C) 3.5 x 1010 7 
Trp (W) 1.3 x 1010 6.5-8.5 
Tyr (Y) 1.3 x 1010 7 
Met (M) 8.5 x 109 6-7 
Phe (F) 6.9 x 109 7-8 
His (H) 4.8 x 109 7.5 
Arg (R) 3.5 x 109 6.5-7.5 
Cystine 2.1 x 109 6.5 
Ile (I) 1.8 x 109 6.6 
Leu (L) 1.7 x 109 ~ 6 
Val (V) 8.5 x 108 6.9 
Pro (P) 6.5 x 108 6.8 
Gln (Q) 5.4 x 108 6.0 
Thr (T) 5.1 x 108 6.6 
Lys (K) 3.5 x 108 6.6 
Ser (S) 3.2 x 108 ~ 6 
Glu (E) 2.3 x 108 6.5 
Ala (A) 7.7 x 107 5.8 
Asp (D) 7.5 x 107 6.9 
Asn (N) 4.9 x 107 6.6 





4.2 Materials and methods 
All of the FPOP labeling and mass spectrometry analyses for this project were performed 
in the NIH/NIGMS Biomedical Mass Spectrometry Resource at the School of Medicine at 




 (UniProt NCOA3_HUMAN) and CBP
2059-2117
 (UniProt CBP_MOUSE) 
domains were co-expressed from a pET22B co-expression vector
(22)
 in Escherichia coli BL21 
(DE3) and separately purified
(9)
 (described in Section 3.2.1). The concentrations of ACTR and 
CBP were 60 µM and 17.2 µM, respectively. Formic acid, hydrogen peroxide (30 %), trypsin, L-
glutamine, L-methionine, catalase, sodium phosphate, sodium chloride, tris-hydrochloride, and 
HPLC-grade solvents were all purchased from Sigma Aldrich (St. Louis, MO). Nu-Tip C-18 zip 
tips were obtained from Glygen Corporation (Columbia, MD).  
4.2.2 FPOP labeling of ACTR and CBP 
 To choose the best condition for ACTR and CBP oxidation, we first performed FPOP 
experiments on free ACTR and CBP separately. In the FPOP reaction, 5 µM of protein samples 
in phosphate buffer (10 mM sodium phosphate, 50 mM sodium chloride, pH 7.0) was mixed 
with glutamine (20 mM) as a radical scavenger limiting the hydroxyl radical lifetime to ~1 µs.
(18)
 
H2O2 was added to the samples just prior to the sample infusion into silica tubing at a flow rate 
of 19.5 µL/min with an exclusion fraction of 20%
(26)
 (the volume not irradiated, existing between 
plugs of the irradiated protein solution, see Section 1.3.4.2). The KrF excimer laser (GAM Laser 
Inc., Orlando, FL) frequency was set to 7 Hz and the average power was 45 mJ. The FPOP 
device setup followed a previously published protocol.
(18)
 The conditions were protein sample 
containing no H2O2, 15 mM H2O2 but no laser irradiation, 7.5 mM H2O2 (half dose) with laser 
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irradiation, and 15 mM H2O2 (full dose) with laser irradiation. After infusing the samples 
through silica tubing and irradiating with laser pulses, the samples were collected in vials 
containing 10 nM catalase (to decompose excess H2O2) and 40 mM methionine (to scavenge 
excess secondary oxidants). These samples were initially analyzed as intact proteins by mass 
spectrometry. 
For binding studies, we performed FPOP experiments on free and bound forms of ACTR 
and CBP. Four sample pools were prepared to represent both ACTR and CBP in free and bound 
forms. The dissociation equilibrium constant for the ACTR:CBP complex is 34 nM.
(22)
 Samples 
containing 5 µM ACTR, 5 µM CBP, 5 µM:25 µM (CBP:ACTR), and 25 µM:5 µM 
(CBP:ACTR) were labeled using the FPOP technique. ACTR:CBP (1:5) will make ACTR 99.8% 
bound while ACTR:CBP (5:1) will make CBP 99.8% bound. For the free forms of ACTR and 
CBP, an equal volume phosphate buffer was substituted for the binding partner. All pools were 
incubated at room temperature for an hour prior to FPOP experiments. 15 mM H2O2 (full dose) 
and 20 mM glutamine were added to each sample prior to labeling with a KrF laser (248nm). 
The same FPOP protocol was followed as described for the intact proteins. The samples were run 
in triplicate. 
4.2.3 Trypsin digestion  
 Following irradiation, a 40 µL aliquot of each sample was mixed with 20 µL of tris 
buffer (100 mM tris-HCl, pH 8.5) and 0.4 µL trypsin (0.1 mg/ml) at an enzyme:protein ratio of 
1:20 (w:w). The solution mixtures were incubated at 37 °C overnight. 40 µL aliquots of the 
digested samples were reconcentrated and cleaned up with NuTip C-18 zip tips and eluted with 
30 µL of 60% acetonitrile/40% H2O/0.1% formic acid. The eluent was then dried and kept at −80 
°C until MS analysis. 
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4.2.4 Mass spectrometry  
 For the ACTR and CBP intact samples, 5 µL of the samples was mixed with 45 µL of 
0.1% formic acid to acidify the solution. The samples were loaded in a silica capillary column, 
custom-packed with C18 revered phase (Magic, 0.075 mm × 150 mm, 5 µm, 120 Å; Michrom 
Bioresources, Inc., Auburn, CA, USA) with a custom-pulled tip. The chromatograph was an 
Ultra 1D+ UPLC (Eksigent, Dublin, CA). The mobile phases were 0.1% formic acid (A) and 
acetonitrile/0.1% formic acid (B). Samples were eluted using the following gradient: 0% B (0 
min), 80% B (60 min), 80% B (70 min), and 0% B (85 min) at 260 nL/min. Mass spectra were 
collected on a LTQ-FT Ultra controlled by Xcalibur 2.2 software (Thermo-Fisher, San Jose, CA, 
USA).  
 For the ACTR and CBP binding studies, the samples were reconstituted in 30 µL of 
water with 0.1% formic acid. The samples were then analyzed on a LTQ Orbitrap XL (Thermo 
Fisher, San Jose, CA) operated in data-dependent acquisition mode. An aliquot of 5 µL of each 
sample was loaded in a silica capillary column, custom-packed with C18 revered phase (Magic, 
0.075 mm × 150 mm, 5 µm, 120 Å) with a custom-pulled tip. The chromatograph was an Ultra 
1D+ UPLC. Peptides were eluted by a 115 min, 260 nL/min gradient coupled to the nanospray 
source. The gradient was as follows: 2% B (0 min), 65% B (80 min), 90% B (90 min), 90% B 
(100 min), 0% B (105 min), and 0% B (115 min). Mass spectra were obtained at high resolving 
power (50,000, FWHH, for ions of m/z 400). For MS/MS analysis, the six most abundant charge 




4.2.5 Data Analysis  
 For peptide-level data analysis, the raw data MS files were converted to profile mzXML 
files by using MassMatrix Mass Spec Data File Converter. The mzXML files of all samples were 
searched against the modified sequence for labeled and unlabeled ACTR and CBP tryptic 
peptides by using MassMatrix 2.4.2 (Case Western Reserve University, Cleveland, OH).
(27)
 All 
the known hydroxyl radical side chain reaction products
(21, 28)
 were added to the MassMatrix 
modification database as variable modifications. Representative MS/MS spectra of modified and 
unmodified CBP peptides (2109-2117) along with their extracted ion chromatograms (EIC) from 
the raw data file are shown in Figure 4.1. From the identified modifications on each tryptic 
peptide, the area under peaks for all modified (AUPox) and the unmodified (AUPunox) form of  
each peptide were determined from the raw data using Xcalibur 2.2. The fractions of 
modification at peptide level were then calculated using equation 1:
(29)
 
 Fraction of modification of peptide =  
∑ AUPox
∑ AUPox+ AUPunox
  (1) 
The value of fraction of modification is one when no unmodified peptide is detected, while the 
value is zero when there is no modification. To quantify the changes in solvent accessibility for 
the ACTR and CBP peptides between the free and bound forms, we calculated protection values 
(PV) using equation 2: 
 Protection value (PV) =  
Fraction modification in free form 
Fraction modification in bound form
              (2)   
The PV was calculated from the ratio of fraction modification of peptide in the free form to the 




Figure 4.1. FPOP data analysis workflow. Product ion (MS/MS) spectra of CBP peptide 2109-
2117 with charge state +2 in the (a) unmodified form and (b) modified form with +16 
modification on methionine 2116, colored in red. The area under peak for the peptide was 
determined from (c) the extracted ion chromatograms of the peptide unmodified (top) and +16 
modified (bottom). The fractions of modification can then be determined from the area under 
peak for the modified (AUPox) and the unmodified (AUPunox) peaks as described by equation 1. 
See text for additional details. 
   
4.3 Results and discussion 
 One of the protein footprinting approaches is FPOP. FPOP can provide structural details 
about a protein or a protein complex with single-residue resolution.
(16, 18, 19)
 This technique uses 
short-lived hydroxyl radicals to label the solvent accessible side chains of proteins. The hydroxyl 
radicals are generated on nanosecond timescales using an excimer laser source. The radical 





Hydroxyl radical has high reactivity that allows irreversible oxidation of 14 of the 20 amino 
acids. The irreversible oxidation of the side chains makes the FPOP technique adaptable to LC-
MS/MS analysis. Probing the solvent accessibility at the residue level makes the FPOP technique 
useful to study protein folding/unfolding, protein-protein binding, and protein epitope 
mapping.
(26, 29, 30)
 Over the last decade, the FPOP technique has been widely used to study folded 
proteins, but there are not many FPOP articles on IDPs. Here we extend the use of FPOP to study 
IDPs and explore the usefulness of the technique to study this class of proteins. We used ACTR 
and CBP as model systems for conformational analysis of IDPs. ACTR is a mostly unstructured 
protein that transiently occupies a folded state as described by NMR and HX-MS.
(9, 22, 25, 31, 32)
 In 
contrast, CBP is a mostly helical molten globule that transiently occupies an unfolded state as 
described by NMR and HX-MS.
(9, 23, 33)
 
4.3.1 FPOP condition selection and global analysis of ACTR and CBP 
 In a typical FPOP experiment, it is necessary to have a mild condition for oxidation 
because the FPOP approach measures solvent accessibility of a protein. Severe oxidation 
conditions can alter the native conformational properties of the protein, which in turn leads to 
very complicated interpretation of the data obtained from FPOP experiments.
(16)
 On the other 
hand, very mild oxidation conditions can limit the range of local conformations that can be 
probed.
(16)
 For this purpose, we compared two different H2O2 concentrations:  half dose (7.5 
mM) and full dose (15 mM) for ACTR and CBP oxidation with the control FPOP experiments 
(no H2O2 and no laser irradiation). The mass spectra are shown in Figure 4.2. The most abundant 
peak for ACTR protein is +7. Therefore, for global data analysis, we used the peak 
corresponding to +7 charge state from the mass spectra of ACTR oxidation at different 
conditions. No oxidations were observed for the control experiments, no H2O2 added with only 
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laser irradiation and H2O2 added with no laser irradiation, for ACTR. With half dose H2O2 for 
FPOP, we only observed increases in the mass of the ACTR protein in three increments of +16 
Da (corresponding to 1103.44, 1105.43, and 1108.07 m/z) as compared to the unmodified protein 
(1101.16 m/z). With full dose H2O2, we observed increases in the mass of the ACTR in five 
increments of +16 Da (corresponding to 1103.44, 1105.43, 1108.07, 1110.31, and 1112.50 m/z). 
We also observed low abundance oxygen loss (−14 Da) product for the ACTR using full dose 
H2O2 condition. According to the chemistry of hydroxyl radical reaction with amino acid site 
chains, oxidation product of −14 Da may correspond to a combination of decarboxylation (−30 
Da) and oxygen addition (+16 Da) on an aspartic or glutamic acid side chain 
(21)
 because ACTR 
has many aspartic and glutamic acid residues. In the same way, for CBP global analysis, we used 
the peak corresponding to +7 charge state from the mass spectra of CBP oxidation under 
different conditions. For the CBP control experiment, no H2O2 added with only laser irradiation, 
two increments of +16 Da were observed. One +16 Da was also observed for the H2O2 added 
with no laser irradiation control condition. CBP has two methionine residues that are highly 
reactive which makes CBP highly susceptible to oxidation even with no H2O2 addition with laser 
irradiation or H2O2 added with no laser irradiation conditions. The oxidation in the control 
conditions does not invalidate the results because such oxidation is low abundance and cancels 
out in free and bound comparisons. With half dose H2O2 for FPOP, we observed increases in the 
mass of the CBP in five increments of +16 Da (corresponding to 940.61, 942.91, 945.21, 947.49, 
and 949.75 m/z) as compared to the unmodified protein (938.37 m/z). With full dose H2O2 for 
FPOP, we observed increases in the mass of the CBP in seven increments of +16 Da 
(corresponding to 940.61, 942.91, 945.21, 947.49, 949.75, 952.08, and 954.36 m/z). Using full 
dose H2O2 condition for CBP, we also observed (−16 Da) product, which may correspond to 
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oxygen loss on an aspartic acid side chain because CBP has one aspartic acid residue. Although 
both H2O2 doses, half and full, provided relatively good conditions for the ACTR and CBP 
oxidation, we selected full H2O2 dose concentration as a base to perform FPOP experiments at 
the peptide level analysis. The reason for using full dose is because the extent of modification for 
all the ACTR and CBP peptides in the free state were at least 0.05, in which the chances for 
observing the actual differences in two protein states is very likely. Thus, with the full H2O2 





Figure 4.2. Global level analysis of (a) ACTR and (b) CBP after FPOP labeling for the protein 
charge state of +7. The FPOP experiments were conducted under four different conditions: no 
H2O2 added to the protein solution with laser irradiation, added 15 mM H2O2 with no laser 




 Although we mainly performed the global FPOP experiments to select the best oxidation 
condition, the data can also be used to compare the extent of oxidation of the two IDPs under the 
same oxidation conditions. For example, using half dose H2O2 conditions for the FPOP, we 
observed three increments of +16 Da for ACTR with low abundance of modifications as 
compared to five increments of +16 Da for CBP with high abundance of modifications. We also 
observed that CBP is more oxidized than ACTR when we compare the full dose H2O2 
experiment for ACTR and CBP. According to global FPOP data, CBP appears to be less 
protected than ACTR. The data are inconsistent with what is expected for ACTR and CBP. 
ACTR is a nearly unstructured protein that transiently occupies a folded state as described by 
NMR and HX-MS.
(9, 22, 31)
 However, CBP is a mostly helical molten globule that transiently 
occupies an unfolded state as described by NMR and HX-MS.
(9, 23, 33)
 The comparison of global 
FPOP data between ACTR and CBP is not very useful. The data cannot provide the structure 
contents when we compare two IDPs to each other. The reason is because the oxidation of a 
given protein or peptide does not only depend on the solvent exposure of the amino acid side 
chains but also depends on the reactivity of the side chains. CBP has more reactive side chains 
than ACTR. Two highly reactive methionine residues are present in the sequence of CBP with 






 (see Table 4.1). Therefore, the FPOP data are not useful for 
comparing the structure content of two different proteins with each other. This is why most 
FPOP applications are comparisons of two states of the same protein. 
4.3.2 Peptide-level FPOP data analysis of ACTR and CBP 
 We performed FPOP labeling of ACTR with full dose H2O2 in the absence and presence 
of five-fold molar excess of CBP. In the same way, we performed FPOP labeling of CBP with 
full dose H2O2 in the absence and presence of five-fold molar excess of ACTR. For ACTR, 
160 
 
tryptic digestion yielded four peptides: ACTR 1023-1031, 1032-1051, 1052-1074, and 1075-
1091. The ACTR sequence coverage was 97%. We observed changes in the extent of 
modification in only two C-terminal peptides when we compared the free form of ACTR with 
the bound form of ACTR. For CBP, tryptic digestion also yielded four peptides: CBP 2062-
2073, 2077-2092, 2093-2103, and 2109-2117. The CBP sequence coverage was 81%. Figure 4.3 
shows the fraction of modification of the ACTR and CBP peptides in their free and bound forms. 
We observed changes in the extent of modification in three peptides when we compared the free 
form CBP with bound form of CBP. The blue colored bars in the Figure 4.3 denote the fraction 
of modification of the peptides obtained from the free forms of the proteins (e.g. 1 ACTR). The 
red colored bars denote the fraction of modification of the peptides obtained from bound forms 
of the protein in the presence of five-fold molar excess of the partner protein (e.g. 1 ACTR: 5 
CBP). We also included the fraction of modification data for the peptides obtained from bound 
forms of the protein but in the presence of five-fold molar excess of the target protein (e.g. 5 
ACTR: 1 CBP) (diamond patterned bars in Figure 4.3). The estimated fraction of modification 
data for (5 ACTR: 1 CBP) (line patterned bars in Figure 4.3) were also included and discussed 
below.  
 We compared the fractions of modification for the free form of ACTR peptides with each 
other (blue colored bars in Figure 4.3a). For example, in the N-terminal peptide of ACTR 1023-
1031, in the absence of CBP, we observed the least modification with the average value of 0.05. 
According to the NMR and HX data, the N-terminal region of ACTR is unstructured in the free 
form,
(9, 22)
 thus we would expect a large fraction of modification. However, we observed the 
opposite result. The low fraction of modification for this region is because this region is enriched 
in amino acid side chains with low reactivity such as glycine, threonine, glutamine, and 
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asparagine (see Table 4.1). On the other hand, for the middle region of ACTR, 1052-1074, we 
observed the highest degree of modification with an average value of 0.8. Again according to the 
NMR and HX data, this region of the free form of ACTR has some residual structure with more 
structuring than the N-terminal region, thus we expected to observe less modification than in the 
N-terminal region of the ACTR. The middle region of ACTR contains relatively more reactive 
side chains. Therefore, the fraction of modification of the free form of ACTR alone is not useful 
for the structural interpretation of the data. Like the global protein analysis, the fractions of 
modification for the free form of ACTR peptides do not report about the relative structure 
contents.    
 We also compared the fractions of modification for the free form of CBP peptides with 
each other (blue colored bars in Figure 4.3b). For example, for the C-terminal peptide of CBP 
2109-2117 in the absence of ACTR, we observed the highest amount of modification with the 
average value of 0.87. According to the NMR and HX data, the N-terminal region of CBP is 
unstructured in the free form
(9, 22)
 and we would expect more modification in the N-terminal 
region than in the C-terminal region. However, we observe the opposite result because the C-
terminal region of CBP contains highly reactive amino acid side chains such as methionine. In 
contrast, we observed less modification for the N-terminal peptides because of the absence of 
highly reactive amino acid side chains. Therefore, the fraction of modification of the free form of 




Figure 4.3. Fractions of modification of (a) ACTR and (b) CBP at the peptide level. The 
fractions of modification were calculated as described in the Materials and Methods section. The 
fractions of modification were determined for ACTR free form (blue bars), ACTR bound to CBP 
at 1:5 molar ratio (red bars), ACTR bound to CBP at 5:1 molar ratio (diamond pattern bars), and 
estimated for ACTR bound to CBP at 5:1 molar ratio (line pattern bars). The fractions of 
modification were determined for CBP free form (blue bars), CBP bound to ACTR at 1:5 molar 
ratio (red bars), CBP bound to ACTR at 5:1 molar ratio (diamond pattern bars), and estimated for 
CBP bound to ACTR at 5:1 molar ratio (line pattern bars). The error bars denote standard 
deviation from triplicate measurements. 
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 To test the reliability of FPOP data, we compared measured with estimated extent of 
modification of peptides obtained from samples with high protein concentrations. This 
comparison would provide information about whether the excess concentration of a protein 
partner has an effect on the dosage of hydroxyl radical delivered to the target protein. For ACTR, 
there are two experiments where the extent of modification of free ACTR peptide is measured: 
[5 μM ACTR, blue bars in Figure 4.3a] and [25 μM ACTR + 5 μM CBP, diamond patterned bars 
in Figure 4.3a]. There are also two experiments where the extent of modification of bound 
ACTR peptide is measured: [25 μM ACTR + μM 5 CBP, diamond pattern bars in Figure 4.3a] 
and [5 μM ACTR + 25 μM CBP, red bars in Figure 4.3a]. In the first experiment, [5 μM ACTR], 
ACTR is 100% free. Based on the equilibrium calculation and the dissociation equilibrium 
constant for ACTR:CBP complex, ACTR is approximately 82% free and 18% bound in the 
second experiment, [25 μM ACTR + 5 μM CBP].  The observed oxidation would then be a 
weighted average of 82% free ACTR and 18% bound ACTR if the extent of oxidation did not 
depend on the presence of CBP. This approximation will only work if the lifetime of the 
hydroxyl radicals is much shorter than the lifetime of the ACTR:CBP complex. If the hydroxyl 
radical lifetime, controlled by hydrogen peroxide concentration and glutamine as radical 
scavenger, is 1 μs, as claimed in Hambly and Gross,
(18)
 then this is probably a reasonable 
assumption. If the hydroxyl radical lifetime is longer than microsecond timeframe, protein 
complex molecules, depending on the dissociation constant, can change from bound to free (or 
reverse) during the lifetime of the radicals, which in turn leading to difficulties in the 
interpretation of the FPOP data. In the fourth experiment, [5 μM ACTR + 25 μM CBP], ACTR is 
approximately 99.8% bound.  Therefore, the extent of modification for each peptide in the 
middle experiment, [25 μM ACTR + 5 μM CBP], was estimated (line patterned bars in Figure 
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4.3a) based on how much modification observed in the other two experiments. In the same way, 
the extent of modification for each peptide of CBP in the middle experiment, [25 μM CBP + 25 
μM ACTR], was estimated (line patterned bars in Figure 4.3b). As shown in the Figure 4.3a, 
there are deviations between the extent of oxidation of measured (diamond patterned bars) from 
the estimated (line patterned bars) for all ACTR peptides. We observed less measured oxidation 
for peptides (1052-1074 and 1075-1091) and more measured oxidation for peptides (1023-1031 
and 1032-1051) than the estimated values. As shown in the Figure 4.3b, there are deviations of 
the extent of oxidation of measured from the estimated for three CBP peptides. We observed less 
measured oxidation for peptides (2093-2103 and 2109-2117) and more measured oxidation for 
peptides (2077-2092) than the estimated values. We also observed that for ACTR and CBP 
regions that become heavily modified, the measured amount of modification is less than 
expected. Whereas in less reactive regions, the measured amount of modification is about the 
expected amount. On the basis of these deviations of measured from estimated oxidation, the 
data indicate that the extra protein sometimes interferes with the hydroxyl radical labeling. One 
of the reasons might be that extra protein consumes the hydroxyl radicals. The other reason 
might be that the hydroxyl radical lifetime is longer than 1 µs as claimed before. In a very recent 
paper,
(34)
 Vahidi and Konermann showed that the oxidation in a typical FPOP experiment might 
extend over tens of millisecond instead of 1 µs. This new millisecond time range for oxidation is 
caused by secondary radicals generated by glutamine scavenger in the FPOP solution. The 
deviations of measured from estimated oxidations could also be explained by both reasons: 
hydroxyl radical consumption by extra protein and extended oxidation over longer timescale than 
1 µs.    
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4.3.3 Regions of decreased solvent accessibility of ACTR upon binding to CBP 
 The extent of oxidation for ACTR can be compared in the absence and presence of CBP. 
Figure 4.3a shows the fraction of modification of each ACTR peptide in the free and bound 
states. The data shown in Figure 4.3a were converted to protection values (PVs) (see equation 2) 
and the PVs were mapped onto the amino acid sequence of ACTR, as shown in Figure 4.4. The 
ACTR peptides, 1023-1031 and 1032-1051, showed no or slight differences in fractions of 
modification between their free and bound forms and the protection values were in the range 0.9 
to 1.2 (see Figure 4.3a and 4.4), suggesting that CBP has no effect on the N-terminal segments of 
ACTR. These peptides are located in the N-terminal region of ACTR which is an important 
region to validate the FPOP approach because NMR and HX data revealed that this region is 
unstructured before and after CBP binding.
(9, 31)
 In contrast, we observed a substantial increase in 
protection from oxidation in ACTR 1052-1074 and 1075-109 upon CBP binding. These peptides 
cover the middle and C-terminal regions of ACTR (see Figure 4.3a and 4.4). The PVs for these 
two peptides were in the range of 1.2-2.5, and the PVs are the highest degree of protection 
observed in ACTR. These ACTR peptides are located in the regions that form α-helices in the 
complex as revealed by NMR. In general, the FPOP data, as protection values, are consistent 




Figure 4.4. Protection values mapped onto the primary and secondary structure of the bound 
form of ACTR for each peptide. The ACTR tryptic peptides shown in gray cover 97% of the 
sequence. The secondary structural elements from the ACTR/CBP complex 
(22)
 are also 
indicated.   
 
4.3.4 Regions of decreased solvent accessibility of CBP upon binding to ACTR 
 The extent of oxidation for CBP can be compared in the absence and presence of ACTR. 
The fraction of modification data from Figure 4.3b were converted to PVs and the PVs were then 
mapped on the amino acid sequence of CBP, as presented in Figure 4.5. The results for most of 
the CBP peptides in the bound form showed increased protection from oxidation relative to the 
free form. For example, binding of ACTR to CBP caused substantial protection from oxidation 
of peptide CBP 2062-2073. We observed a 3-fold increase in protection from oxidation for this 
peptide located in the N-terminal region of CBP. This is the highest amount of protection 
observed across the sequence of CBP. The C-terminal CBP peptides, 2093-2103 and 2109-2117, 
were also protected from oxidation as shown in Figure 4.5, but the change in the amount of 
protection is not as much in the N-terminal segment of CBP. The PVs for the C-terminal 
peptides were in the range of 1.2-2.5. The data suggest that the N- and C-terminal regions of 
CBP become more tightly folded upon binding to ACTR. In general, we observed good 





 On the other hand, there is one peptide, CBP 2077-2092, in the middle region of 
CBP that showed no difference in the protection between the free and bound forms of CBP. This 
peptide covers a turn between α1 and α2-helices that is not affected by binding. We observed the 
lowest amount of PV for this peptide across all regions of CBP. The data for this region do not 
agree well with NMR and HX data. The reason is because this peptide is enriched in residues 
that have side chains with low reactivity with hydroxyl radicals: asparagine, serine, lysine, and 
glutamine. The weakly reactive side chains may decrease the ability to measure the degree of 
changes in the protection for the CBP 2077-2092.  
 
Figure 4.5. Protections values mapped onto the primary and secondary structure of the bound 
form of CBP for each peptide. The CBP tryptic peptides shown in gray cover 81% of the 
sequence. The secondary structural elements from the ACTR/CBP complex 
(22)
 are also 
indicated.    
 
The FPOP data for ACTR and CBP illustrate the potential usefulness of FPOP analysis to 
characterize and localize regions of binding induced folding of IDPs. However, FPOP may not 
work for all kinds of IDPs, and especially IDPs that are highly enriched in amino acids that are 
weakly reactive with hydroxyl radicals. Amino acids predicted to be enriched in IDPs, including 





 Whereas many amino acids that are enriched in ordered proteins, including 
tryptophan, phenylalanine, cysteine, and isoleucine, generally react more quickly with hydroxyl 
radicals relative to other amino acids (see Table 4.1).
(21, 35)
 Unlike HX, the application of the 
FPOP method to interpret the structure content of the free forms of a protein is not very useful. 
The reason is because in the FPOP method, the measured extent of oxidation of a given peptide 
largely depends not only on the solvent exposure of the amino acid side chains in the protein’s 
structure but also the reactivity of amino acid side chains with hydroxyl radicals. When a protein 
contains amino acid side chains with low reactivity, then the chances of obtaining structural 
informational are less.  
In order to confidently characterize conformational change of a protein under various 
conditions, the FPOP method can be used as a stand-alone method or it can work as a 
complementary technique to other techniques such as HX that can probe protein structure. The 
FPOP method would be beneficial to achieve high spatial resolution for protein conformation 
and dynamic studies, but if a protein is enriched in amino acid side chains with low reactivity, 
FPOP cannot be very useful. There are also problems associated with FPOP experiments. One of 
the problems is reproducibility. The reproducibility of FPOP experiments highly depends on the 
ability to deliver a defined concentration of hydroxyl radicals to the protein of interest. 
Delivering a defined concentration of radicals not only depends on the amount of radicals 
generated and presence of radical scavenger, but also depends on some other factors: the 
concentration of the proteins in the FPOP solution, buffer components, and even the geometry of 
each FPOP setup that may alter the amount of radicals produced and delivered to the protein 
target. In such cases, to measure a defined concentration of hydroxyl radicals generated and 
delivered to the protein target and reliably measure oxidation of the protein, a radical dosimeter 
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is required in FPOP experiment. Recently, adenine as a radical dosimeter has been reported to 
measure the effective hydroxyl radicals delivered to the protein of interest.
(37)
 The reason for 
selecting adenine as a radical dosimeter is due to its quantitative relationship between UV 
spectrophotometric response, hydroxyl radical dose, and protein oxidation levels. One other 
problem associated with FPOP is the radical lifetime available for protein labeling. The radical 
lifetime subject is still under debate.
(18, 26, 34)
 As mentioned before, the hydroxyl radical lifetime 
is claimed to be ~1 µs, and in such time frame protein labeling will be complete before 
conformational changes can take place.
(18, 26)
 A recent article suggests that the oxidation can 
extend over milliseconds through secondary radical products produced from reaction of hydroxyl 
radicals with glutamine scavenger in FPOP solution.
(34)
 If the new time frame for radical lifetime 
is correct, the oxidation might impact the native conformation of a target protein. In cases of 
long-lived radicals, the problems could also arise if the oxidation is not much faster than the 
on/off rate for the protein complex. 
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 Intrinsically disordered proteins (IDPs) are a class of proteins that exhibit a high degree 
of conformational flexibility and lack a structured conformation under physiological conditions, 
but are still functional.
(1-3)
 IDP functionality arises in a different manner as compared to the 
classical structure-function model of ordered proteins. There has been a growing interest in IDPs 
due to their important roles in many biological processes and functions. Highly dynamic 
conformations in IDPs mediate protein-protein interaction through the phenomenon of coupled 
folding and binding.
(4-6)
 Two extreme mechanisms have been proposed to describe this 
phenomenon: conformational selection and induced folding.
(7, 8)
 The differentiation of these two 
mechanisms is an ongoing challenge. More detailed information is required to understand the 
complexity of mechanisms of protein-protein interaction involving disordered proteins. Also, 
localized information about the presence or absence of transiently folded conformers of IDPs in 
the free state can be very important to provide support for one proposed mechanism over the 
other. Since IDPs are unfolded or partially unfolded and are very flexible, they have a high 
solvent accessible surface. These properties of IDPs represent a challenge for biophysical 
techniques to analyze this class of proteins. Over the past two decades, mass spectrometry (MS) 
has become a powerful technique for biophysical characterization of proteins due to its high 
sensitivity and variety of choices for sample preparation and instrumentation.
(9-11)
 This 
dissertation presented examples of the application of two important mass spectrometry-based 
approaches: hydrogen exchange (HX) and fast photochemical oxidation of proteins (FPOP) to 
study disordered protein systems. The data illustrate the usefulness of the mass spectrometry-
based approaches to characterize and localize regions of protein-protein interactions involving 
intrinsically disordered proteins. 
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5.2 Chapter summaries and future directions 
5.2.1 Chapter 2 
 HX-MS was applied to better understand the mechanism of calcineurin activation. 
Calcineurin is a heterodimeric phosphatase that plays essential roles in cellular processes. 
Previous work has established that at high calcium concentration, calmodulin binds calcium ions, 
resulting in calmodulin binding to the intrinsically disordered regulatory domain of 
calcineurin.
(12-14)
 Calmodulin binding causes release of the autoinhibitory domain from the active 
site, activating calcineurin. Our results with full-length calcineurin demonstrated that the 
regulatory domain is unstructured in the absence of calmodulin, while it folds upon binding to 
calmodulin. This result confirms previous work on the isolated regulatory-autoinhibitory domain 
construct.
(12)
 Additionally, we have observed calmodulin-induced changes in peptides located in 
other domains of calcineurin. Finally, and most surprisingly, we found no changes in the 
structuring of the calcineurin autoinhibitory domain upon calmodulin binding. We presented 
results from all regions of the calcineurin to describe the mechanism of calcineurin activation. 
We also proposed a new model of calcineurin activation upon calmodulin binding. 
 The HX data presented in Chapter 2 described only two states of calcineurin at high 
calcium concentrations: free and bound to calmodulin. There is limited information about 
calcineurin conformation at no or low calcium concentrations in the absence of calmodulin. The 
available information about calcineurin in this state is based on limited proteolysis and some 
other low resolution biochemical studies. According to previous studies, in the absence of 
calcium and calmodulin, the calmodulin-binding domain and autoinhibitory domain of the 
calcineurin regulatory domain are protected against proteolytic attack, indicating these two 





To investigate the complex multistep regulatory mechanism of calcineurin activation and have a 
complete story of the activation, future studies on calcineurin in the absence of calcium in 
solution will be required. It will be interesting to perform HX-MS experiments to study 
calcineurin in the absence of calcium state. For this purpose, HX-MS can be performed on 
calcineurin in the absence and presence of EDTA as a calcium free state. 
 According to the HX data presented in Chapter 2, we also observed calcineurin 
conformational changes in the C-terminal region of calcineurin B chain and the region 
immediately N-terminal to the autoinhibitory domain of calcineurin A chain. We suggested that 
the C-terminal region of calcineurin B and the region immediately N-terminal to the 
autoinhibitory domain may interact with calmodulin to anchor calmodulin to the binding site. To 
confirm that there is an interaction between the C-terminal region of calcineurin B and 
calmodulin, we also need to study calmodulin conformational changes at high calcium 
concentration in the presence and absence of calcineurin using HX-MS. The HX-MS experiment 
will be challenging. The reason is because calmodulin itself undergoes conformational change 
when it bound to calmodulin binding domain of calcineurin.
(12, 15)
 Thus, distinguishing between 
HX protection at the calcineurin-calmodulin interface from binding-induced folding of 
calmodulin will not be easy. However, a control HX experiment will be required in such cases. 
HX-MS on calmodulin in the presence of calmodulin binding domain peptide can be used as a 
control experiment. The HX data of the control experiment will then be compared with HX data 
for the calmodulin in the presence of calcineurin to be able to observe if there is interaction 
between the C-terminal region of calcinerin B chain and calmodulin. 
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5.2.2 Chapter 3 
 The degree of structure measurement in IDPs can provide important information about 
the mechanisms by which IDPs undergo coupled folding and binding. Different approaches to 
quantify the degree of structure in IDPs using millisecond HX were explored. A quench-flow 
device, built in-house,
(16)
 for HX labeling on the millisecond timescale was employed. It is 
essentially impossible to determine the degree of structure without having an accurate 
unprotected reference state. The interaction domains of the activator for thyroid and retinoid 
receptors (ACTR) and the CREB binding protein (CBP) were used as model IDPs to explore the 
best approach to produce an unprotected reference state for millisecond HX. ACTR is a near-
random coil IDP that has some residual helicity while CBP is a molten globular IDP that 
transiently becomes unstructured as revealed by NMR and HX-MS.
(17-19)
 The approaches 
explored to obtain an unprotected reference state in HX experiments were chemical exchange 
calculations, addition of denaturing agents, and millisecond HX labeling of peptic peptides 
obtained from the IDP. We found that peptic reference peptides can be used as an accurate 
unprotected reference state for determining the degree of the structure. 
 The approach for determining the degree of structure discussed in Chapter 3 may not 
work for all types of proteins. If a peptide can form structure even after protein digestion, then 
these peptides cannot act as an unprotected reference peptide. This approach could be a problem 
for globular proteins that have a much stronger tendency to fold. This could also be a problem 
for IDPs that contain regions that have a strong tendency to fold. It will be interesting to develop 
a method to account for such issues. One possible method is by using peptic peptide in a low 
denaturant concentration as an unprotected reference state for the degree of structure 
quantification at high resolution. 
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 Since we successfully applied the approach discussed in Chapter 3 to quantify the degree 
of structure of ACTR and CBP as two model IDPs, it will be interesting to perform similar 
studies to quantify the degree of structure of calcineurin in the absence of calmodulin. This 
experiment will provide structural and flexibility information about calcineurin with a very 
simple and easy to apply experimental setup.  
5.2.3 Chapter 4 
Due to its fast labeling timeframe, FPOP might reveal states of IDPs that are undetectable 
by HX. The application of the FPOP technique for characterizing IDPs was evaluated. To 
explore the applicability of this technique for studying IDPs, ACTR and CBP as model systems 
that co-fold upon binding were used. The FPOP technique was utilized to study ACTR and CBP 
in their free and bound forms. The data showed that FPOP can provide useful information to 
compare two states of IDPs. The usefulness and limitations of FPOP analysis to characterize and 
localize regions of protein-protein interactions involving IDPs were illustrated. 
In the Chapter 4, we discussed problems associated with FPOP techniques to study 
proteins. We also tested whether the excess concentration of a protein partner has an effect on 
the dosage of hydroxyl radical delivered to the target protein. On the basis of the data presented, 
we concluded that the extra protein sometimes interferes with the hydroxyl radical labeling. One 
of the reasons might be that extra protein consumes the hydroxyl radicals. In such cases, the 
reproducibility of the experiment will be affected because the reproducibility of FPOP 
experiments highly depends on the ability to deliver a defined concentration of hydroxyl radicals 
to the protein of interest. As a continuation of this research, two approaches can be explored to 
solve the excess concentration problem. In the first approach, a protein, which does not interact 
with the proteins under study, can be added to the protein mixture to compensate for the excess 
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protein concentration in the FPOP experiment and have the total protein concentration constant. 
For example, 4-fold molar excess of carbonic anhydrase, as a concentration normalizing 
additive, can be added to (1 ACTR: 4 CBP) complex, and 4-fold molar excess of carbonic 
anhydrase can be added to (4 ACTR: 1 CBP) complex to compensate for the excess 
concentration problem. Another approach to measure a defined concentration of hydroxyl 
radicals generated and delivered to the protein target is by introducing a radical dosimeter into 
the FPOP experiment. Adenine, which has been previously used as a radical dosimeter,
(20)
 can be 
tested for ACTR and CBP experiment to normalize the FPOP data according to different 
oxidation conditions. 
Another approach to improve the FPOP experiment to be able to characterize and 
determine the degree of structure in IDPs in their free state is by introducing a reference state. 
The idea of introducing a reference state is similar to the idea explained in Chapter 3 for 
millisecond hydrogen exchange. The only difference here for FPOP experiment, the amino acid 
side chains of the reference state would be unprotected from oxidation. For this experiment, 
since ACTR and CBP are small proteins, 
15
N-labeled tryptic peptides of ACTR and CBP might 
be used as unprotected reference state to measure protection from oxidation of ACTR and CBP 
separately. This experiment would also need a radical dosimetry to reliably measure the 
oxidation, and adenine can be tested here as well.    
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